Cover
Cover - shares | 9 Months Ended | |
Mar. 31, 2023 | Apr. 30, 2023 | |
Cover [Abstract] | ||
Document Type | 10-Q | |
Document Quarterly Report | true | |
Document Period End Date | Mar. 31, 2023 | |
Document Transition Report | false | |
Entity File Number | 001-34717 | |
Entity Registrant Name | Alpha and Omega Semiconductor Limited | |
Entity Incorporation, State or Country Code | D0 | |
Entity Tax Identification Number | 77-0553536 | |
Entity Address, Address Line One | Clarendon House | |
Entity Address, Address Line Two | 2 Church Street | |
Entity Address, City or Town | Hamilton | |
Entity Address, Postal Zip Code | HM 11 | |
Entity Address, Country | BM | |
City Area Code | 408 | |
Local Phone Number | 830-9742 | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Large Accelerated Filer | |
Entity Small Business | false | |
Entity Emerging Growth Company | false | |
Title of 12(b) Security | Common Shares | |
Trading Symbol | AOSL | |
Security Exchange Name | NASDAQ | |
Entity Shell Company | false | |
Entity Common Stock, Shares Outstanding (in shares) | 27,488,761 | |
Entity Central Index Key | 0001387467 | |
Current Fiscal Year End Date | --06-30 | |
Document Fiscal Year Focus | 2023 | |
Document Fiscal Period Focus | Q3 | |
Amendment Flag | false |
CONDENSED CONSOLIDATED BALANCE
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Mar. 31, 2023 | Jun. 30, 2022 |
Current assets: | ||
Cash and cash equivalents | $ 265,946 | $ 314,352 |
Restricted cash | 218 | 299 |
Accounts receivable, net | 19,434 | 65,681 |
Inventories | 179,783 | 158,040 |
Other current assets | 9,969 | 11,220 |
Total current assets | 475,350 | 549,592 |
Property, plant and equipment, net | 358,157 | 318,666 |
Operating lease right-of-use assets | 22,962 | 23,674 |
Intangible assets, net | 7,577 | 10,050 |
Equity method investment | 368,042 | 378,378 |
Deferred income tax assets | 561 | 592 |
Other long-term assets | 20,658 | 17,677 |
Total assets | 1,253,307 | 1,298,629 |
Current liabilities: | ||
Accounts payable | 54,689 | 87,377 |
Accrued liabilities | 90,029 | 116,893 |
Payable related to equity investee, net | 18,393 | 28,989 |
Income taxes payable | 6,651 | 4,248 |
Short-term debt | 24,877 | 25,563 |
Deferred revenue | 14,370 | 0 |
Finance lease liabilities | 851 | 802 |
Operating lease liabilities | 4,457 | 3,850 |
Total current liabilities | 214,317 | 267,722 |
Long-term debt | 41,237 | 42,486 |
Income taxes payable - long-term | 2,261 | 2,158 |
Deferred income tax liabilities | 27,764 | 28,757 |
Finance lease liabilities - long-term | 3,439 | 3,932 |
Operating lease liabilities - long-term | 19,332 | 20,878 |
Other long-term liabilities | 57,699 | 78,603 |
Total liabilities | 366,049 | 444,536 |
Commitments and contingencies (Note 12) | ||
Preferred shares, par value $0.002 per share: | ||
Authorized: 10,000 shares; issued and outstanding: none at March 31, 2023 and June 30, 2022 | 0 | 0 |
Common shares, par value $0.002 per share: | ||
Authorized: 100,000 shares; issued and outstanding: 34,575 shares and 27,858 shares, respectively at March 31, 2023 and 33,988 shares and 27,371 shares, respectively at June 30, 2022 | 69 | 68 |
Treasury shares at cost: 6,717 shares at March 31, 2023 and 6,617 shares at June 30, 2022 | (68,605) | (66,000) |
Additional paid-in capital | 321,548 | 288,951 |
Accumulated other comprehensive income (loss) | (9,156) | 1,080 |
Retained earnings | 643,402 | 629,994 |
Total Alpha and Omega Semiconductor Limited shareholder's equity | 887,258 | 854,093 |
Total liabilities and equity | $ 1,253,307 | $ 1,298,629 |
CONSOLIDATED BALANCE SHEETS (Pa
CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares | Mar. 31, 2023 | Jun. 30, 2022 |
Preferred stock, par value (in dollars per share) | $ 0.002 | $ 0.002 |
Preferred stock, shares authorized (in shares) | 10,000,000 | 10,000,000 |
Preferred stock, shares issued (in shares) | 0 | 0 |
Preferred stock, shares outstanding (in shares) | 0 | 0 |
Common shares, par value (in dollars per share) | $ 0.002 | $ 0.002 |
Common shares, authorized (in shares) | 100,000,000 | 100,000,000 |
Common stock, shares issued (in shares) | 34,575,000 | 33,988,000 |
Common stock, shares outstanding (in shares) | 27,858,000 | 27,371,000 |
Treasury shares (in shares) | 6,717,000 | 6,617,000 |
CONDENSED CONSOLIDATED STATEMEN
CONDENSED CONSOLIDATED STATEMENTS OF INCOME - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Mar. 31, 2023 | Mar. 31, 2022 | Mar. 31, 2023 | Mar. 31, 2022 | |
Income Statement [Abstract] | ||||
Revenue | $ 132,560 | $ 203,239 | $ 529,796 | $ 583,593 |
Cost of goods sold | 101,774 | 130,837 | 374,841 | 378,259 |
Gross profit | 30,786 | 72,402 | 154,955 | 205,334 |
Operating expenses | ||||
Research and development | 22,578 | 16,545 | 65,435 | 50,873 |
Selling, general and administrative | 22,610 | 24,625 | 69,603 | 70,563 |
Total operating expenses | 45,188 | 41,170 | 135,038 | 121,436 |
Operating income (loss) | (14,402) | 31,232 | 19,917 | 83,898 |
Other income (loss), net | (513) | 263 | (1,432) | 720 |
Interest income (expense), net | 5 | (308) | (1,000) | (3,025) |
Gain on deconsolidation of the JV Company | 0 | 0 | 0 | 399,093 |
Gain (loss) on changes of equity interest in the JV Company, net | 0 | 4,501 | 0 | (3,140) |
Net income including noncontrolling interest | (14,910) | 35,688 | 17,485 | 477,546 |
Income tax expense | 2,517 | 2,902 | 5,550 | 38,318 |
Net income (loss) before income (loss) from equity method investment | (17,427) | 32,786 | 11,935 | 439,228 |
Equity method investment income (loss) from equity investee | (1,480) | (1,136) | 1,533 | (1,136) |
Net income (loss) including noncontrolling interest | (18,907) | 31,650 | 13,468 | 438,092 |
Net loss attributable to noncontrolling interest | 0 | 0 | 0 | 20 |
Net income (loss) attributable to Alpha and Omega Semiconductor Limited | $ (18,907) | $ 31,650 | $ 13,468 | $ 438,072 |
Net income (loss) per common share attributable to Alpha and Omega Semiconductor Limited | ||||
Basic (in dollars per share) | $ (0.68) | $ 1.18 | $ 0.49 | $ 16.47 |
Diluted (in dollars per share) | $ (0.68) | $ 1.11 | $ 0.46 | $ 15.58 |
Weighted average number of common shares attributable to Alpha and Omega Semiconductor Limited used to compute net income (loss) per share | ||||
Basic (in shares) | 27,710 | 26,829 | 27,537 | 26,596 |
Diluted (in shares) | 27,710 | 28,423 | 29,576 | 28,116 |
CONDENSED CONSOLIDATED STATEM_2
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Mar. 31, 2023 | Mar. 31, 2022 | Mar. 31, 2023 | Mar. 31, 2022 | |
Statement of Comprehensive Income [Abstract] | ||||
Net income (loss) including noncontrolling interest | $ (18,907) | $ 31,650 | $ 13,468 | $ 438,092 |
Other comprehensive income (loss), net of tax | ||||
Foreign currency translation adjustment | 3,748 | 162 | (10,236) | 1,649 |
Cumulative translation adjustment removal due to deconsolidation of the JV Company | 0 | (3,642) | ||
Comprehensive income (loss) | (15,159) | 31,812 | 3,232 | 436,099 |
Less: Noncontrolling interest | 0 | 0 | (1,080) | |
Comprehensive income (loss) attributable to Alpha and Omega Semiconductor Limited | $ (15,159) | $ 31,812 | $ 3,232 | $ 437,179 |
CONSOLIDATED STATEMENTS OF SHAR
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($) shares in Thousands, $ in Thousands | Total | Total AOS Shareholders' Equity | Common Shares | Treasury Stock | Additional Paid-In Capital | Accumulated Other Comprehensive Income (Loss) | Retained Earnings | Noncontrolling Interest |
Increase (Decrease) in Stockholders' Equity | ||||||||
Beginning balance, including portion attributable to noncontrolling interest | $ 516,325 | |||||||
Beginning balance at Jun. 30, 2021 | $ 373,205 | $ 66 | $ (66,064) | $ 259,993 | $ 2,315 | $ 176,895 | ||
Beginning balance, noncontrolling interest at Jun. 30, 2021 | $ 143,120 | |||||||
Increase (Decrease) in Stockholders' Equity | ||||||||
Exercise of common stock options and release of restricted stock units | 859 | 859 | 859 | |||||
Reissuance of treasury stock upon exercise of common stock options and release of RSUs | 0 | 58 | (58) | |||||
Withholding tax on restricted stock units | (8,354) | (8,354) | (8,354) | |||||
Issuance of shares under ESPP | 2,423 | 2,423 | 2,422 | |||||
Issuance of shares under ESPP (in shares) | 1 | |||||||
Share-based compensation | 21,189 | 21,189 | 21,189 | |||||
Restricted stock units settlement in connection with service | 400 | 400 | 400 | |||||
Net loss | 438,072 | 438,072 | 438,072 | |||||
Net loss attributable to noncontrolling interest | 20 | 20 | ||||||
Net income (loss) including noncontrolling interest | 438,092 | |||||||
Cumulative translation adjustment | 900 | 900 | ||||||
Cumulative translation adjustment, attributable to noncontrolling interest | 749 | |||||||
Foreign currency translation adjustment | 1,649 | |||||||
Deconsolidation of non controlling interest | (145,682) | (1,793) | (1,793) | (143,889) | ||||
Ending balance at Mar. 31, 2022 | 826,901 | $ 67 | (66,006) | 276,509 | 1,422 | 614,909 | ||
Ending balance, noncontrolling interest at Mar. 31, 2022 | 0 | |||||||
Ending balance, including portion attributable to noncontrolling interest at Mar. 31, 2022 | 826,901 | |||||||
Increase (Decrease) in Stockholders' Equity | ||||||||
Beginning balance, including portion attributable to noncontrolling interest | 793,990 | |||||||
Beginning balance at Dec. 31, 2021 | 793,990 | 67 | (66,046) | 275,410 | 1,260 | 583,299 | ||
Beginning balance, noncontrolling interest at Dec. 31, 2021 | 0 | |||||||
Increase (Decrease) in Stockholders' Equity | ||||||||
Exercise of common stock options and release of restricted stock units | 558 | 558 | 558 | |||||
Reissuance of treasury stock upon exercise of common stock options and release of RSUs | 40 | (40) | ||||||
Withholding tax on restricted stock units | (7,732) | (7,732) | (7,732) | |||||
Share-based compensation | 8,273 | 8,273 | 8,273 | |||||
Net loss | 31,650 | 31,650 | 31,650 | |||||
Net loss attributable to noncontrolling interest | 0 | |||||||
Net income (loss) including noncontrolling interest | 31,650 | |||||||
Cumulative translation adjustment | 162 | 162 | ||||||
Foreign currency translation adjustment | 162 | |||||||
Ending balance at Mar. 31, 2022 | 826,901 | 67 | (66,006) | 276,509 | 1,422 | 614,909 | ||
Ending balance, noncontrolling interest at Mar. 31, 2022 | 0 | |||||||
Ending balance, including portion attributable to noncontrolling interest at Mar. 31, 2022 | 826,901 | |||||||
Increase (Decrease) in Stockholders' Equity | ||||||||
Beginning balance, including portion attributable to noncontrolling interest | 826,901 | |||||||
Beginning balance, including portion attributable to noncontrolling interest | 854,093 | |||||||
Beginning balance at Jun. 30, 2022 | 854,093 | 854,093 | $ 68 | (66,000) | 288,951 | 1,080 | 629,994 | |
Beginning balance, noncontrolling interest at Jun. 30, 2022 | 0 | |||||||
Increase (Decrease) in Stockholders' Equity | ||||||||
Exercise of common stock options and release of restricted stock units | 551 | 551 | 550 | |||||
Exercise of common stock options and release of restricted stock units (in shares) | 1 | |||||||
Reissuance of treasury stock upon exercise of common stock options and release of RSUs | 0 | 60 | (60) | |||||
Withholding tax on restricted stock units | (6,152) | (6,152) | (6,152) | |||||
Issuance of shares under ESPP | 4,080 | 4,080 | 4,080 | |||||
Repurchase of common shares under shares repurchase program | (2,665) | (2,665) | (2,665) | |||||
Share-based compensation | 34,119 | 34,119 | 34,119 | |||||
Net loss | 13,468 | 13,468 | 13,468 | |||||
Net loss attributable to noncontrolling interest | 0 | |||||||
Net income (loss) including noncontrolling interest | 13,468 | |||||||
Cumulative translation adjustment | (10,236) | (10,236) | ||||||
Foreign currency translation adjustment | (10,236) | |||||||
Ending balance at Mar. 31, 2023 | 887,258 | 887,258 | $ 69 | (68,605) | 321,548 | (9,156) | 643,402 | |
Ending balance, noncontrolling interest at Mar. 31, 2023 | 0 | |||||||
Ending balance, including portion attributable to noncontrolling interest at Mar. 31, 2023 | 887,258 | |||||||
Increase (Decrease) in Stockholders' Equity | ||||||||
Beginning balance, including portion attributable to noncontrolling interest | 899,674 | |||||||
Beginning balance at Dec. 31, 2022 | 899,674 | $ 68 | (65,990) | 316,141 | (12,904) | 662,359 | ||
Beginning balance, noncontrolling interest at Dec. 31, 2022 | 0 | |||||||
Increase (Decrease) in Stockholders' Equity | ||||||||
Exercise of common stock options and release of restricted stock units | 532 | 532 | 531 | |||||
Exercise of common stock options and release of restricted stock units (in shares) | 1 | |||||||
Reissuance of treasury stock upon exercise of common stock options and release of RSUs | 50 | (50) | ||||||
Withholding tax on restricted stock units | (5,556) | (5,556) | (5,556) | |||||
Repurchase of common shares under shares repurchase program | (2,665) | (2,665) | (2,665) | |||||
Share-based compensation | 10,432 | 10,432 | 10,432 | |||||
Net loss | (18,907) | (18,907) | (18,907) | |||||
Net loss attributable to noncontrolling interest | 0 | |||||||
Net income (loss) including noncontrolling interest | (18,907) | |||||||
Cumulative translation adjustment | 3,748 | 3,748 | ||||||
Foreign currency translation adjustment | 3,748 | |||||||
Ending balance at Mar. 31, 2023 | 887,258 | $ 887,258 | $ 69 | $ (68,605) | $ 321,548 | $ (9,156) | $ 643,402 | |
Ending balance, noncontrolling interest at Mar. 31, 2023 | $ 0 | |||||||
Ending balance, including portion attributable to noncontrolling interest at Mar. 31, 2023 | 887,258 | |||||||
Increase (Decrease) in Stockholders' Equity | ||||||||
Beginning balance, including portion attributable to noncontrolling interest | $ 887,258 |
CONDENSED CONSOLIDATED STATEM_3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands | 9 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Cash flows from operating activities | ||
Net income (loss) including noncontrolling interest | $ 13,468 | $ 438,092 |
Adjustments to reconcile net income to net cash provided by operating activities: | ||
Gain on deconsolidation of the JV Company | 0 | (399,093) |
Loss on changes of equity interest in the JV Company, net | 0 | 3,140 |
Deferred income tax on deconsolidation and changes of equity interest in the JV Company | 0 | 29,973 |
Depreciation and amortization | 31,162 | 34,263 |
Equity method investment income (loss) from equity investee | (1,533) | 1,136 |
Share-based compensation expense | 34,119 | 21,454 |
Deferred income taxes, net | (962) | 2,182 |
Loss on disposal of property and equipment | 387 | 57 |
Changes in operating assets and liabilities | ||
Accounts receivable | 46,247 | (3,610) |
Inventories | (21,744) | (42,914) |
Other current and long-term assets | (7,824) | (10,078) |
Accounts payable | (21,581) | 15,608 |
Net payable, equity investee | (10,595) | 34,375 |
Income taxes payable | 2,506 | (1) |
Income taxes payable on deconsolidation and changes of equity interest in the JV Company | 0 | 3,490 |
Increase in deferred revenue | 14,370 | 0 |
Accrued and other liabilities | (29,366) | 65,122 |
Net cash provided by operating activities | 48,654 | 193,196 |
Cash flows from investing activities | ||
Proceeds from sale of equity interest in the JV Company | 0 | 26,347 |
Deconsolidation of cash and cash equivalents of the JV Company | 0 | (20,734) |
Purchases of property and equipment | (91,261) | (98,006) |
Proceeds from sale of property and equipment | 27 | 9 |
Government grant related to equipment | 631 | 1,242 |
Net cash used in investing activities | (90,603) | (91,142) |
Cash flows from financing activities | ||
Withholding tax on restricted stock units | (6,152) | (8,354) |
Proceeds from exercise of stock options and ESPP | 4,631 | 3,282 |
Payment for repurchases of common shares | (2,665) | 0 |
Proceeds from borrowings | 8,632 | 59,262 |
Repayments of borrowings | (10,260) | (33,663) |
Principal payments on finance leases | (603) | (4,176) |
Net cash provided by (used in) financing activities | (6,417) | 16,351 |
Effect of exchange rate changes on cash, cash equivalents and restricted cash | (121) | 152 |
Net increase (decrease) in cash, cash equivalents and restricted cash | (48,487) | 118,557 |
Cash, cash equivalents and restricted cash at beginning of period | 314,651 | 204,813 |
Cash, cash equivalents and restricted cash at end of period | 266,164 | 323,370 |
Supplemental disclosures of non-cash investing and financing information: | ||
Property and equipment purchased but not yet paid | 17,298 | 25,565 |
Reconciliation of cash, cash equivalents, and restricted cash: | ||
Cash and cash equivalents | 265,946 | 323,134 |
Restricted cash | 218 | 236 |
Total cash, cash equivalents, and restricted cash | $ 266,164 | $ 323,370 |
The Company and Significant Acc
The Company and Significant Accounting Policies | Jan. 26, 2022 |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
The Company and Significant Accounting Policies | The Company and Significant Accounting Policies The Company Alpha and Omega Semiconductor Limited and its subsidiaries (the “Company”, “AOS”, “we” or “us”) design, develop and supply a broad range of power semiconductors. The Company's portfolio of products targets high-volume applications, including personal and portable computers, graphic cards, flat panel TVs, home appliances, smart phones, battery packs, quick chargers, home appliances, consumer and industrial motor controls and power supplies for TVs, computers, servers and telecommunications equipment. The Company conducts its operations primarily in the United States of America (“USA”), Hong Kong, China, and South Korea. Basis of Preparation The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) for interim financial information and with the instructions to Article 10 of Securities and Exchange Commission Regulation S-X, as amended. They do not include all information and footnotes necessary for a fair presentation of financial position, results of operations and cash flows in conformity with U.S. GAAP for complete financial statements. These Condensed Consolidated Financial Statements should be read in conjunction with the consolidated financial statements and related notes contained in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2022. All significant intercompany balances and transactions have been eliminated in consolidation. In the opinion of management, all adjustments (consisting of normal recurring adjustments and accruals) considered necessary for a fair presentation of the results of operations for the periods presented have been included in the interim periods. Operating results for the nine months ended March 31, 2023 are not necessarily indicative of the results that may be expected for the fiscal year ending June 30, 2023 or any other interim period. The consolidated balance sheet at June 30, 2022 is derived from the audited financial statements included in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2022. Reclassification The Company has reclassified certain amounts previously reported in its financial statements to conform to the current presentation. See Note 11. Joint Venture On March 29, 2016, the Company entered into a joint venture contract (the “JV Agreement”) with two investment funds owned by the Municipality of Chongqing (the “Chongqing Funds”), pursuant to which the Company and the Chongqing Funds formed a joint venture, (the “JV Company”), for the purpose of constructing and operating a power semiconductor packaging, testing and 12-inch wafer fabrication facility in the Liangjiang New Area of Chongqing, China (the “JV Transaction”). As of December 1, 2021, the Company owned 50.9%, and the Chongqing Funds owned 49.1%, of the equity interest in the JV Company. The Joint Venture was accounted under the provisions of the consolidation guidance since the Company had controlling financial interest until December 1, 2021. As of December 2, 2021, the Company ceased having control over the JV Company. Therefore, the Company deconsolidated the JV Company as of that date. Subsequently, the Company has accounted for its investment in the JV Company using the equity method of accounting. As of March 31, 2023, the percentage of outstanding JV equity interest beneficially owned by the Company was reduced to 42.2%. Such reduction reflects (i) the sale by the Company of approximately 2.1% of the outstanding JV equity interest which resulted in the deconsolidation of the JV Company, (ii) additional sale by the Company of approximately 1.1% of outstanding JV equity interest in December 2021, (iii) the adoption of an employee equity incentive plan and the issuance of additional equity interest equivalent to 3.99% of the JV Company to investors in exchange for cash in December 2021, and (iv) issuance of additional equity interest of JV to investors in January 2022. Certain Significant Risks and Uncertainties Related to Outbreak of Coronavirus Disease 2019 (“COVID-19”) During the first half of calendar year 2022, the Company's operations were negatively impacted by China’s zero-Covid policy that resulted in factory shutdowns and supply chain shortages, including the temporary suspension of its factory operations in Shanghai from April to June 2022. In December 2022, the Chinese government issued new guidelines easing some of its strict zero-COVID policies, including the relaxation of testing requirements and travel restrictions. The change of COVID-policy and reopening of commercial activities resulted in a significant increase of COVID infections in China, which may adversely affect the Company’s operations in China. During the three months ended March 31, 2023, as China and other parts of the world in which we conduct our business have ended pandemic restriction have largely returned to normal. In general, our business operations are no longer affected by the COVID-19 pandemic. Use of Estimates The preparation of the consolidated financial statements in conformity with U.S. GAAP requires the Company to make estimates, judgments and assumptions that affect the reported amounts of assets, liabilities, revenue and expenses. To the extent there are material differences between these estimates and actual results, the Company's condensed consolidated financial statements will be affected. On an ongoing basis, the Company evaluates the estimates, judgments and assumptions including those related to stock rotation returns, price adjustments, allowance for doubtful accounts, inventory reserves, warranty accrual, income taxes, leases, share-based compensation, recoverability of and useful lives for property, plant and equipment and intangible assets, as well as the economic implications of the COVID-19 pandemic. Leases The Company determines if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (“ROU”) assets, current operating lease liabilities and long-term operating lease liabilities on the Company's Condensed Consolidated Balance Sheets. Finance leases are included in property, plant and equipment, finance lease liabilities and long-term finance leases liabilities on the Condensed Consolidated Balance Sheets. Operating lease ROU assets and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. The Company uses an estimate of its incremental borrowing rate based on the information available at the lease commencement date. The operating lease ROU assets also include any lease payments made and exclude lease incentives. Lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise such options. Operating lease expense is generally recognized on a straight-line basis over the lease term. Variable lease payments are expensed as incurred and are not included within the operating lease ROU asset and lease liability calculation. The Company does not record leases on the Condensed Consolidated Balance Sheet with a term of one year or less. The Company elected to combine its lease and non-lease components as a single lease component for all asset classes. Revenue recognition The Company determines revenue recognition through the following steps: (1) identification of the contract with a customer; (2) identification of the performance obligations in the contract; (3) determination of the transaction price; (4) allocation of the transaction price to the performance obligations in the contract; and (5) recognition of revenue when, or as, a performance obligation is satisfied. The Company recognizes product revenue at a point in time when product is shipped to the customer, net of estimated stock rotation returns and price adjustments that it expects to provide to certain distributors. The Company presents revenue net of sales taxes and any similar assessments. Our standard payment terms range from 30 to 60 days. The Company sells its products primarily to distributors, who in turn sell the products globally to various end customers. The Company allows stock rotation returns from certain distributors. Stock rotation returns are governed by contract and are limited to a specified percentage of the monetary value of products purchased by distributors during a specified period. The Company records an allowance for stock rotation returns based on historical returns and individual distributor agreements. The Company also provides special pricing to certain distributors, primarily based on volume, to encourage resale of the Company’s products. Allowance for price adjustments is recorded against accounts receivable and the provision for stock rotation rights is included in accrued liabilities on the Condensed Consolidated Balance Sheets. The Company’s performance obligations relate to contracts with a duration of less than one year. The Company elected to apply the practical expedient provided in ASC 606, “Revenue from Contracts with Customers”. Therefore, the Company is not required to disclose the aggregate amount of transaction price allocated to performance obligations that are unsatisfied or partially unsatisfied at the end of the reporting period. The Company recognizes the incremental direct costs of obtaining a contract, which consist of sales commissions, when control over the products they relate to transfers to the customer. Applying the practical expedient, the Company recognizes commissions as expense when incurred, as the amortization period of the commission asset the Company would have otherwise recognized is less than one year. Packaging and testing services revenue is recognized at a point in time upon shipment of serviced products to the customer. License and Development Revenue Recognition In February 2023, the Company entered into a license agreement with a customer to license the Company’s proprietary SiC technology and to provide 24-month engineering and development services for a total fee of $45 million, consisting of an upfront fee of $18 million paid to the Company in March 2023, and the remaining amount to be paid upon the achievement of specified engineering services and product milestones. The license and development fee is determined to be one performance obligation and is recognized over the 24 months when the Company performs the engineering and development services. The Company uses the input method to measure progression, representing a faithful depiction of the transfer of services. During the three months ended March 31, 2023, the Company recorded $3.6 million of license and development revenue. The amount of contract liability is recorded as deferred revenue on the balance sheets. In addition, the Company also entered an accompanying supply agreement to provide limited wafer supply to the customer. Material right to the customer is presented due to the commitment of limited wafer supply after the development period; however, deemed to be insignificant to the transaction price. Share-based Compensation Expense The Company maintains an equity-settled, share-based compensation plan to grant restricted share units and stock options. The Company recognizes expense related to share-based compensation awards that are ultimately expected to vest based on estimated fair values on the date of grant. The fair value of restricted share units is based on the fair value of the Company's common share on the date of grant. For restricted stock awards subject to market conditions, the fair value of each restricted stock award is estimated at the date of grant using the Monte-Carlo pricing model. The fair value of stock options is estimated on the date of grant using the Black-Scholes option valuation model. Share-based compensation expense is recognized on the accelerated attribution basis over the requisite service period of the award, which generally equals the vesting period. The Employee Share Purchase Plan (the “ESPP”) is accounted for at fair value on the date of grant using the Black-Scholes option valuation model. Restricted Cash The Company maintains restricted cash in connection with cash balances temporarily restricted for regular business operations. These balances have been excluded from the Company’s cash and cash equivalents balance and are classified as restricted cash in the Company’s Condensed Consolidated Balance Sheets. As of March 31, 2023 and June 30, 2022, the amount of restricted cash was $0.2 million and $0.3 million, respectively. Equity method investment The Company uses the equity method of accounting when it has the ability to exercise significant influence, but not control, as determined in accordance with generally accepted accounting principles, over the operating and financial policies of the investee. Effective December 2, 2021, the Company reduced its equity interest in the JV Company and no longer controls of the JV Company. As a result, beginning December 2, 2021, the Company records its investment under the equity method of accounting. Since the Company is unable to obtain accurate financial information from the JV Company in a timely manner, the Company records its share of earnings or losses of such affiliate on a one quarter lag. The Company discloses and recognizes intervening events at the JV Company in the lag period that could materially affect our consolidated financial statements, if applicable. The Company records its interest in the net earnings of the equity method investee, along with adjustments for unrealized profits or losses on intra-entity transactions and amortization of basis differences, within earnings or loss from equity interests in the Consolidated Statements of Income. Profits or losses related to intra-entity sales with the equity method investee are eliminated until realized by the investor and investee. Basis differences represent differences between the cost of the investment and the underlying equity in net assets of the investment and are generally amortized over the lives of the related assets that gave rise to them. Equity method goodwill is not amortized or tested for impairment; instead the equity method investment is tested for impairment. The Company reviews for impairment whenever factors indicate that the carrying amount of the investment might not be recoverable. In such a case, the decrease in value is recognized in the period the impairment occurs in the Condensed Consolidated Statements of Income. Valuation of inventories The Company carries inventories at the lower of cost (determined on a first-in, first-out basis) or net realizable value. Cost primarily consists of semiconductor wafers and raw materials, labor, depreciation expenses and other manufacturing expenses and overhead, and packaging and testing fees paid to third parties if subcontractors are used. Valuation of inventories is based on its periodic review of inventory quantities on hand as compared with its sales forecasts, historical usage, aging of inventories, production yield levels and current product selling prices. If actual market conditions are less favorable than those forecasted by the Company, additional future inventory write-downs may be required that could adversely affect its operating results. Adjustments to inventory, once established are not reversed until the related inventory has been sold or scrapped. If actual market conditions are more favorable than expected and the products that have previously been written down are sold, our gross margin would be favorably impacted. Fair Value of Financial Instruments The fair value of cash equivalents is categorized in Level 1 in the fair value hierarchy. Cash equivalents consist primarily of short-term bank deposits. The carrying values of financial instruments such as cash and cash equivalents, accounts receivable and accounts payable approximate their carrying values due to their short-term maturities. The carrying value of the Company's debt is considered a reasonable estimate of fair value which is estimated by considering the current rates available to the Company for debt of the same remaining maturities, structure, credit risk and terms of the debts. Government Grants The Company occasionally receives government grants that provide financial assistance for certain eligible expenditures in China. These grants include reimbursements on interest expense on bank borrowings, payroll tax credits, credit for property, plant and equipment in a particular geographical location, employment credits, as well as business expansion credits. Government grants are not recognized until there is reasonable assurance that the Company will comply with the conditions attaching to it, and that the grant will be received. The Company records such grants either as a reduction of the related expense, a reduction of the cost of the related asset, or as other income depending upon the nature of the grant. As a result of such grants, during the three and nine months ended March 31, 2023, the Company reduced property, plant and equipment by nil and $0.6 million, and operating expenses by $0.0 million and $0.1 million, respectively. During the three and nine months ended March 31, 2022, the Company reduced interest expense by nil and $0.9 million, property, plant and equipment by nil and $1.2 million, and operating expenses by $0.0 million and $0.2 million, respectively. Accounting for income taxes Income tax expense or benefit is based on income or loss before income taxes. Deferred tax assets and liabilities are recognized principally for the expected tax consequences of temporary differences between the tax basis of assets and liabilities and their reported amounts. The Company is subject to income taxes in a number of jurisdictions. Significant judgment is required in determining the worldwide provision for income taxes. There are many transactions and calculations for which the ultimate tax determination is uncertain during the ordinary course of business. The Company establishes accruals for certain tax contingencies based on estimates of whether additional taxes may be due. While the final tax outcome of these matters may differ from the amounts that were initially recorded, such differences will impact the income tax and deferred tax provisions in the period in which such determination is made. Significant management judgment is also required in determining whether deferred tax assets will be realized in full or in part. When it is more likely than not that all or some portion of specific deferred tax assets such as net operating losses or research and development tax credit carryforwards will not be realized, a valuation allowance must be established for the amount of the deferred tax assets that cannot be realized. The Company considers all available positive and negative evidence on a jurisdiction-by-jurisdiction basis when assessing whether it is more likely than not that deferred tax assets are recoverable. The Company considers evidence such as our past operating results, the existence of cumulative losses in recent years and our forecast of future taxable income. The Financial Accounting Standards Board (FASB), issued guidance which clarifies the accounting for income taxes by prescribing a minimum probability threshold that a tax position must meet before a financial statement benefit is recognized. The minimum threshold is defined as a tax position that is more likely than not to be sustained upon examination by the applicable taxing authority, including resolution of any related appeals or litigation processes, based on the technical merits of the position. The tax benefit to be recognized is measured as the largest amount of benefit that is greater than fifty percent likely to be realized upon ultimate settlement. Although the guidance on the accounting for uncertainty in income taxes prescribes the use of a recognition and measurement model, the determination of whether an uncertain tax position has met those thresholds will continue to require significant judgment by management. If the ultimate resolution of tax uncertainties is different from what is currently estimated, a material impact on income tax expense could result. The Company's provision for income taxes is subject to volatility and could be adversely impacted by changes in earnings or tax laws and regulations in various jurisdictions. The Company is subject to the continuous examination of our income tax returns by the Internal Revenue Service and other tax authorities. The Company regularly assesses the likelihood of adverse outcomes resulting from these examinations to determine the adequacy of our provision for income taxes. To the extent that the final tax outcome of these matters is different from the amounts recorded, such differences will impact the provision for income taxes in the period in which such determination is made. The provision for income taxes includes the impact of changes to reserves, as well as the related net interest and penalties. Long-lived Assets The Company reviews all long-lived assets whenever events or changes in circumstance indicate that these assets may not be recoverable. When evaluating long-lived assets, if the Company concludes that the estimated undiscounted cash flows attributable to the assets are less than their carrying value, the Company recognizes an impairment loss based on the excess of the carrying amount of the assets over their respective fair values, which could adversely affect its results of operations. Comprehensive Income Comprehensive income is defined as the change in equity of a business enterprise during a period from transactions and other events and circumstances from non-owner sources. The Company's accumulated other comprehensive income consists of cumulative foreign currency translation adjustments. Total comprehensive income is presented in the Condensed Consolidated Statements of Comprehensive Income. Recent Accounting Pronouncements Recently Issued Accounting Standards not yet adopted In September 2022, the FASB issued ASU No. 2022-04, "Liabilities - Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations". This ASU was issued in response to requests from financial statement users for increased transparency surrounding the use of supplier finance programs. The amendments in ASU 2022-04 require that a buyer in a supplier finance program disclose sufficient information about the program to allow a user of financial statements to understand the program’s nature, activity during the period, changes from period to period, and potential magnitude. The amendments in this ASU do not affect the recognition, measurement, or financial statement presentation of obligations covered by supplier finance programs. The amendments in this ASU are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, except for the amendment on rollforward information, which is effective for fiscal years beginning after December 15, 2023. Early adoption is permitted. The Company is currently evaluating the impact of adopting this guidance. Recently Adopted Accounting Standards In November 2021, the FASB issued Accounting Standards Update (ASU) No. 2021-10, Government Assistance (Topic 832): Disclosures by Business Entities about Government Assistance. This ASU requires business entities to make annual disclosures about transactions with a government they account for by analogizing to a grant or contribution accounting model under ASC 958-605. The adoption of ASU 2021-10 had no impact on the Company's Consolidated Financial Statements. In August 2020, the FASB issued ASU No. 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity, which, among other things, provides guidance on how to account for contracts on an entity’s own equity. This ASU simplifies the accounting for certain financial instruments with characteristics of liabilities and equity. Specifically, the ASU eliminated the need for the Company to assess whether a contract on the entity’s own equity (1) permits settlement in unregistered shares, (2) whether counterparty rights rank higher than shareholder’s rights, and (3) whether collateral is required. In addition, the ASU requires incremental disclosure related to contracts on the entity’s own equity and clarifies the treatment of certain financial instruments accounted for under this ASU on earnings per share. The adoption of ASU 2020-06 had no impact on the Company's Consolidated Financial Statements. |
Equity Method Investment in Equ
Equity Method Investment in Equity Investee | 9 Months Ended |
Mar. 31, 2023 | |
Discontinued Operations and Disposal Groups [Abstract] | |
Equity Method Investment in Equity Investee | Equity Method Investment in Equity Investee On December 1, 2021 (the “Effective Date”), Alpha & Omega Semiconductor (Shanghai) Ltd. (“AOS SH”) and Agape Package Manufacturing (Shanghai) Limited (“APM SH” and, together with AOS SH, the “Sellers”), each a wholly-owned subsidiary of the Company, entered into a share transfer agreement ("STA") with a third-party investor to sell a portion of the Company's equity interest in the JV Company which consists of a power semiconductor packaging, testing and 12-inch wafer fabrication facility in Chongqing, China (the “Transaction”). The Transaction closed on December 2, 2021 (the “Closing Date”), which reduced the Company’s equity interest in the JV Company from 50.9% to 48.8%. Also, the Company’s right to designate directors on the board of JV Company was reduced to three (3) out of seven (7) directors, from four (4) directors prior to the Transaction. As a result of the Transaction and other factors, the Company no longer has a controlling financial interest in the JV Company and has determined that the JV Company was deconsolidated from the Company’s Consolidated Financial Statements effective as of the Closing Date. On December 24, 2021, the Company entered into a share transfer agreement with another third-party investor, pursuant to which the Company sold to this investor 1.1% of outstanding equity interest held by the Company in the JV Company. In addition, the JV Company adopted an employee equity incentive plan and issued an equity interest equivalent to 3.99% of the JV Company in exchange to cash. As a result of these two transactions, the Company owned 45.8% of the equity interest in the JV Company as of December 31, 2021. On January 26, 2022, the JV Company completed a financing transaction pursuant to a corporate investment agreement (the “Investment Agreement”) between the JV Company and certain third-party investors (the “New Investors”). Under the Investment Agreement, the New Investors purchased newly issued equity interest of the JV Company, representing approximately 7.82% of post-transaction outstanding equity interests of the JV Company, for a total purchase price of RMB 509 million (or approximately USD 80 million based on the currency exchange rate as of January 26, 2022) (the “Investment”). Following the closing of the Investment and as of June 30, 2022, the percentage of outstanding JV equity interest beneficially owned by the Company was reduced to 42.2%. The Company accounts for its investment in the JV Company as an equity method investment and reports its equity in earnings or loss of the JV Company on a three-month lag due to an inability to timely obtain financial information of the JV Company. During the three and nine months ended March 31, 2023, the Company recorded a $1.5 million in loss and a $1.5 million income of its equity share of the JV Company, respectively, using lag reporting. As of March 31, 2023, the percentage of outstanding JV equity interest beneficially owned by the Company was 42.2%. |
Related Party Transactions
Related Party Transactions | 9 Months Ended |
Mar. 31, 2023 | |
Related Party Transactions [Abstract] | |
Related Party Transactions | Related Party TransactionsAs of March 31, 2023, the Company owned 42.2% equity interest in the JV Company, which, by definition, is a related party to the Company. The JV Company supplies 12-inch wafers and provides assembly and testing services to AOS. AOS previously sold 8-inch wafers to the JV Company for further assembly and testing services until January 1, 2023, when it changed to consign the 8-inch wafers to the JV Company. Due to the right of offset of receivables and payables with the JV Company, as of March 31, 2023, AOS recorded the net amount of $18.4 million presented as payable related to equity investee, net, in the Condensed Consolidated Balance Sheet. The purchases by AOS for the three and nine months ended March 31, 2023 were $20.2 million and $106.1 million, respectively, and the sales by AOS for the three and nine months ended March 31, 2023 were $4.0 million and $34.4 million, respectively. The purchases by AOS for the three and nine months ended March 31, 2022 were $45.8 million and $61.4 million, respectively, and the sales by AOS for the three and nine months ended March 31, 2022 were $14.2 million and $18.4 million, respectively. |
Net Income (Loss) Per Common Sh
Net Income (Loss) Per Common Share Attributable to Alpha and Omega Semiconductor Limited | 9 Months Ended |
Mar. 31, 2023 | |
Earnings Per Share [Abstract] | |
Net Income (Loss) Per Common Share Attributable to Alpha and Omega Semiconductor Limited | Net Income (Loss) Per Common Share Attributable to Alpha and Omega Semiconductor Limited The following table presents the calculation of basic and diluted net income (loss) per share attributable to common shareholders: Three Months Ended March 31, Nine Months Ended March 31, 2023 2022 2023 2022 (in thousands, except per share data) Numerator: Net income (loss) attributable to Alpha and Omega Semiconductor Limited $ (18,907) $ 31,650 $ 13,468 $ 438,072 Denominator: Basic: Weighted average number of common shares used to compute basic net income (loss) per share 27,710 26,829 27,537 26,596 Diluted: Weighted average number of common shares used to compute basic net income (loss) per share 27,710 26,829 27,537 26,596 Effect of potentially dilutive securities: Stock options, RSUs and ESPP shares — 1,594 2,039 1,520 Weighted average number of common shares used to compute diluted net income (loss) per share 27,710 28,423 29,576 28,116 Net income (loss) per share attributable to Alpha and Omega Semiconductor Limited: Basic $ (0.68) $ 1.18 $ 0.49 $ 16.47 Diluted $ (0.68) $ 1.11 $ 0.46 $ 15.58 The following potential dilutive securities were excluded from the computation of diluted net income (loss) per share as their effect would have been anti-dilutive: Three Months Ended March 31, Nine Months Ended March 31, 2023 2022 2023 2022 (in thousands) (in thousands) Employee stock options and RSUs 3,152 2 281 171 ESPP 767 19 279 27 Total potential dilutive securities 3,919 21 560 198 |
Concentration of Credit Risk an
Concentration of Credit Risk and Significant Customers | 9 Months Ended |
Mar. 31, 2023 | |
Risks and Uncertainties [Abstract] | |
Concentration of Credit Risk and Significant Customers | Concentration of Credit Risk and Significant Customers The Company manages its credit risk associated with exposure to distributors and direct customers on outstanding accounts receivable through the application and review of credit approvals, credit ratings and other monitoring procedures. In some instances, the Company also obtains letters of credit from certain customers. Credit sales, which are mainly on credit terms of 30 to 60 days, are only made to customers who meet the Company's credit requirements, while sales to new customers or customers with low credit ratings are usually made on an advance payment basis. The Company considers its trade accounts receivable to be of good credit quality because its key distributors and direct customers have long-standing business relationships with the Company and the Company has not experienced any significant bad debt write-offs of accounts receivable in the past. The Company closely monitors the aging of accounts receivable from its distributors and direct customers, and regularly reviews their financial positions, where available. Summarized below are individual customers whose revenue or accounts receivable balances were 10% or higher than the respective total consolidated amounts: Three Months Ended March 31, Nine Months Ended March 31, Percentage of revenue 2023 2022 2023 2022 Customer A 21.0 % 24.2 % 21.7 % 24.8 % Customer B 28.7 % 38.8 % 35.5 % 38.7 % Customer C 17.9 % * 14.1 % * March 31, June 30, Percentage of accounts receivable Customer A * 24.6 % Customer B * 36.4 % Customer C 46.0 % 12.0 % Customer D 21.9 % * |
Balance Sheet Components
Balance Sheet Components | 9 Months Ended |
Mar. 31, 2023 | |
Balance Sheet Related Disclosures [Abstract] | |
Balance Sheet Components | Balance Sheet Components Accounts receivable, net: March 31, June 30, (in thousands) Accounts receivable $ 54,269 $ 84,442 Less: Allowance for price adjustments (34,805) (18,731) Less: Allowance for doubtful accounts (30) (30) Accounts receivable, net $ 19,434 $ 65,681 Inventories: March 31, June 30, (in thousands) Raw materials $ 86,490 $ 67,960 Work-in-process 69,905 80,720 Finished goods 23,388 9,360 $ 179,783 $ 158,040 Other current assets: March 31, June 30, (in thousands) Value-added tax receivable $ 179 $ 737 Other prepaid expenses 3,950 3,954 Prepaid insurance 751 2,590 Prepaid maintenance 1,092 826 Prepayment to supplier 71 257 Prepaid income tax 2,176 2,086 Interest receivable 172 25 Other receivables 1,578 745 $ 9,969 $ 11,220 Property, plant and equipment, net: March 31, June 30, (in thousands) Land $ 4,877 $ 4,877 Building 26,243 16,691 Manufacturing machinery and equipment 320,087 287,574 Equipment and tooling 31,428 28,052 Computer equipment and software 49,425 46,758 Office furniture and equipment 3,175 2,820 Leasehold improvements 38,051 35,254 473,286 422,026 Less: accumulated depreciation (261,814) (233,340) 211,472 188,686 Equipment and construction in progress 146,685 129,980 Property, plant and equipment, net $ 358,157 $ 318,666 Intangible assets, net: March 31, June 30, (in thousands) Patents and technology rights $ 18,037 $ 18,037 Trade name 268 268 Customer relationships 1,150 1,150 19,455 19,455 Less: accumulated amortization (12,147) (9,674) 7,308 9,781 Goodwill 269 269 Intangible assets, net $ 7,577 $ 10,050 Estimated future minimum amortization expense of intangible assets is as follows (in thousands): Year ending June 30, 2023 (Remaining) $ 812 2024 3,249 2025 3,247 $ 7,308 Other long-term assets: March 31, June 30, (in thousands) Prepayments for property and equipment $ 1,013 $ 6,890 Investment in a privately held company 100 100 Customs deposit 2,118 1,708 Deposit with supplier 13,040 6,396 Other long-term deposits 33 18 Office leases deposits 1,243 1,012 Other 3,111 1,553 $ 20,658 $ 17,677 Accrued liabilities: March 31, June 30, (in thousands) Accrued compensation and benefits $ 18,750 $ 34,681 Warranty accrual 3,815 2,650 Stock rotation accrual 4,081 4,798 Accrued professional fees 2,407 2,659 Accrued inventory 1,322 2,491 Accrued facilities related expenses 2,285 2,421 Accrued property, plant and equipment 6,531 20,485 Other accrued expenses 4,160 5,159 Customer deposits 43,314 40,578 ESPP payable 3,364 971 $ 90,029 $ 116,893 Short-term customer deposits are payments received from customers for securing future product shipments. As of March 31, 2023, $12.5 million were from Customer A and $10.2 million were from Customer B, and $20.6 million were from other customers. As of June 30, 2022, $12.5 million were from Customer A and $16.2 million were from Customer B, and $11.9 million were from other customers. The activities in the warranty accrual, included in accrued liabilities, are as follows: Nine Months Ended March 31, 2023 2022 (in thousands) Beginning balance $ 2,650 $ 2,795 Additions 2,915 949 Utilization (1,750) (1,261) Ending balance $ 3,815 $ 2,483 The activities in the stock rotation accrual, included in accrued liabilities, are as follows: Nine Months Ended March 31, 2023 2022 (in thousands) Beginning balance $ 4,798 $ 3,917 Additions 9,187 3,030 Utilization (9,904) (2,740) Ending balance $ 4,081 $ 4,207 Other long-term liabilities: March 31, June 30, (in thousands) Customer deposits $ 51,926 $ 70,301 Computer software liabilities 5,773 8,302 Other long-term liabilities $ 57,699 $ 78,603 Customer deposits are payments received from customers for securing future product shipments. As of March 31, 2023, $22.0 million were from Customer A and $13.7 million were from Customer B, and $16.2 million were from other customers. As of June 30, 2022, $34.5 million were from Customer A and $21.9 million were from Customer B, and $13.9 million were from other customers. |
Bank Borrowing Bank Borrowing
Bank Borrowing Bank Borrowing | 9 Months Ended |
Mar. 31, 2023 | |
Debt Disclosure [Abstract] | |
Bank Borrowing | Bank Borrowings Short-term borrowings In January 2023, one of the Company's subsidiaries in China entered into a line of credit facility with Bank of Communications Limited in China. The purpose of the credit facility is to provide working capital borrowings. The Company could borrow up to approximately RMB 140 million or $20.6 million based on currency exchange rate between RMB and U.S. Dollar on January 31, 2023 with a maturity date of December 1, 2023. As of March 31, 2023, there was no outstanding balance for this loan. Accounts Receivable Factoring Agreement On August 9, 2019, one of the Company's wholly-owned subsidiaries (the “Borrower”) entered into a factoring agreement with the Hongkong and Shanghai Banking Corporation Limited (“HSBC”), whereby the Borrower assigns certain of its accounts receivable with recourse. This factoring agreement allows the Borrower to borrow up to 70% of the net amount of its eligible accounts receivable of the Borrower with a maximum amount of $30.0 million. The interest rate is based on one month London Interbank Offered Rate (“LIBOR”) plus 1.75% per annum. The Company is the guarantor for this agreement. The Company is accounting for this transaction as a secured borrowing under the Transfers and Servicing of Financial Assets guidance. In addition, any cash held in the restricted bank account controlled by HSBC has a legal right of offset against the borrowing. This agreement, with certain financial covenants required, has no expiration date. On August 11, 2021, the Borrower signed an agreement with HSBC to decrease the borrowing maximum amount to $8.0 million with certain financial covenants required. Other terms remain the same. As of March 31, 2023, the Borrower was in compliance with these covenants. As of March 31, 2023, there was no outstanding balance and the Company had unused credit of approximately $8.0 million. Debt financing In September 2021, Jireh Semiconductor Incorporated (“Jireh”), one of the wholly-owned subsidiaries, entered into a financing arrangement agreement with a company (“Lender”) for the lease and purchase of a machinery equipment manufactured by a supplier. This agreement has a 5 years term, after which Jireh has the option to purchase the equipment for $1. The implied interest rate was 4.75% per annum which was adjustable based on every five basis point increase in 60-month U.S. Treasury Notes, until the final installation and acceptance of the equipment . The total purchase price of this equipment was euro 12.0 million. In April 2021, Jireh made a down payment of euro 6.0 million, representing 50% of the total purchase price of the equipment, to the supplier. In June 2022, the equipment was delivered to Jireh after Lender paid 40% of the total purchase price, for euro 4.8 million, to the supplier on behalf of Jireh. In September 2022, Lender paid the remaining 10% payment for the total purchase price and reimbursed Jireh for the 50% down payment, after the installation and configuration of the equipment. The title of the equipment was transferred to Lender following such payment. The agreement was amended with fixed implied interest rate of 7.51% and monthly payment of principal and interest effective in October 2022. Other terms remain the same. In addition, Jireh purchased hardware for the machine under this financing arrangement. The purchase price of this hardware was $0.2 million. The financing arrangement is secured by this equipment and other equipment which had the carrying amount of $13.1 million as of March 31, 2023. As of March 31, 2023, the outstanding balance of this debt financing was $12.5 million. Long-term bank borrowings On August 18, 2021, Jireh entered into a term loan agreement with a financial institution (the "Bank") in an amount up to $45.0 million for the purpose of expanding and upgrading the Company’s fabrication facility located in Oregon. The obligation under the loan agreement is secured by substantially all assets of Jireh and guaranteed by the Company. The agreement has a 5.5 year term and matures on February 16, 2027. Jireh is required to make consecutive quarterly payments of principal and interest. The loan accrues interest based on adjusted LIBOR plus the applicable margin based on the outstanding balance of the loan. This agreement contains customary restrictive covenants and includes certain financial covenants that the Company is required to maintain. Jireh drew down $45.0 million on February 16, 2022 with the first payment of principal beginning in October 2022. As of March 31, 2023, Jireh was in compliance with these covenants and the outstanding balance of this loan was $40.5 million. On May 1, 2018, Jireh entered into a loan agreement with the Bank that provided a term loan in the amount of $17.8 million. The obligation under the loan agreement is secured by certain real estate assets of Jireh and guaranteed by the Company. The loan has a five-year term. Beginning June 1, 2018, Jireh made consecutive monthly payments of principal and interest to the Bank. The outstanding principal accrues interest at a fixed rate of 5.04% per annum on the basis of a 360-day year. The loan agreement contains customary restrictive covenants and includes certain financial covenants that require the Company to maintain, on a consolidated basis, specified financial ratios. In August 2021, Jireh signed an amendment of this loan with the Bank to modify the financial covenants requirement to align with the new term loan agreement entered into on August 18, 2021 discussed above. The amendment was accounted for as a debt modification and no gain or loss was recognized. The Company was in compliance with these covenants as of March 31, 2023. As of March 31, 2023, the outstanding balance of the term loa n was $13.5 million. The Company paid this loan in full on May 1, 2023. Maturities of short-term debt and long-term debt were as follows (in thousands): Year ending June 30, 2023 (Remaining) $ 16,339 2024 11,472 2025 11,664 2026 11,871 2027 14,344 Thereafter 536 Total principal 66,226 Less: debt issuance costs (112) Total principal, less debt issuance costs $ 66,114 Short-term Debt Long-term Debt Total Principal amount $ 24,925 $ 41,301 $ 66,226 Less: debt issuance costs (48) (64) (112) Total debt, less debt issuance costs $ 24,877 $ 41,237 $ 66,114 |
Leases
Leases | 9 Months Ended |
Mar. 31, 2023 | |
Leases [Abstract] | |
Leases | Leases The Company evaluates contracts for lease accounting at contract inception and assesses lease classification at the lease commencement date. Operating leases are included in operating lease right-of-use (“ROU”) assets, operating lease liabilities and operating lease liabilities - long-term on the Company's Condensed Consolidated Balance Sheets. Finance leases are included in property, plant and equipment, finance lease liabilities and finance lease liabilities-long-term on the Condensed Consolidated Balance Sheets. The Company recognizes a ROU asset and corresponding lease obligation liability at the lease commencement date where the lease obligation liability is measured at the present value of the minimum lease payments. As most of the leases do not provide an implicit rate, the Company uses its incremental borrowing rate at lease commencement. The Company uses an interest rate commensurate with the interest rate to borrow on a collateralized basis over a similar term with an amount equal to the lease payments. Operating leases are primarily related to offices, research and development facilities, sales and marketing facilities, and manufacturing facilities. In addition, long-term supply agreements to lease gas tank equipment and purchase industrial gases are accounted for as operating leases. Lease agreements frequently include renewal provisions and require the Company to pay real estate taxes, insurance and maintenance costs. For operating leases, the amortization of the ROU asset and the accretion of its lease obligation liability result in a single straight-line expense recognized over the lease term. The finance lease is related to the $5.1 million of a machinery lease financing with a vendor. In September 2022, the lease was amended to make a monthly payment of principal and interest as a fixed amount effective in October 2022. Other terms remain the same. The amendment was accounted for as a debt modification and no gain or loss was recognized. In addition, the finance lease related to the RMB 400.0 million of lease financing of the JV Company with YinHai Leasing Company and The Export-Import Bank of China was not included in the Company’s unaudited Condensed Consolidated Balance Sheet at March 31, 2023 due to the deconsolidation of the JV Company on December 2, 2021. The Company does not record leases on the Condensed Consolidated Balance Sheets with a term of one year or less. The Company’s unaudited Condensed Consolidated Statements of Income for the nine months ended March 31, 2022 include the JV Company's results for the period preceding the deconsolidation on December 2, 2021. The components of the Company’s operating and finance lease expenses are as follows for the periods presented (in thousands): Three Months Ended March 31, Nine Months Ended March 31, 2023 2022 2023 2022 Operating leases: Fixed rent expense $ 1,385 $ 1,479 $ 4,298 $ 4,955 Variable rent expense 279 126 757 741 Finance lease: Amortization of equipment 128 15 393 787 Interest 83 11 227 692 Short-term leases Short-term lease expenses 133 38 300 144 Total lease expenses $ 2,008 $ 1,669 $ 5,975 $ 7,319 Supplemental balance sheets information related to the Company’s operating and finance leases is as follows (in thousands, except lease term and discount rate): March 31, June 30, Operating Leases : ROU assets associated with operating leases $ 22,962 $ 23,674 Finance Lease: Property, plant and equipment, gross $ 5,133 $ 4,831 Accumulated depreciation (529) (136) Property, plant and equipment, net $ 4,604 $ 4,695 Weighted average remaining lease term (in years) Operating leases 6.65 7.42 Finance lease 4.50 5.00 Weighted average discount rate Operating leases 4.39 % 4.27 % Finance lease 7.51 % 4.76 % Supplemental cash flow information related to the Company’s operating and finance lease is as follows (in thousands): Nine Months Ended March 31, 2023 2022 Cash paid from amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 4,418 $ 4,965 Operating cash flows from finance lease $ 227 $ 421 Financing cash flows from finance lease $ 603 $ 4,176 Non-cash investing and financing information: Operating lease right-of-use assets obtained in exchange for lease obligations $ 2,859 $ 5,901 Future minimum lease payments are as follows as of March 31, 2023 (in thousands): Year ending June 30, Operating Leases Finance Leases The remainder of fiscal 2023 $ 1,481 $ 286 2024 5,006 1,144 2025 4,133 1,144 2026 3,441 1,144 2027 3,264 1,145 Thereafter 10,301 191 Total minimum lease payments 27,626 5,054 Less amount representing interest (3,837) (764) Total lease liabilities $ 23,789 $ 4,290 |
Leases | Leases The Company evaluates contracts for lease accounting at contract inception and assesses lease classification at the lease commencement date. Operating leases are included in operating lease right-of-use (“ROU”) assets, operating lease liabilities and operating lease liabilities - long-term on the Company's Condensed Consolidated Balance Sheets. Finance leases are included in property, plant and equipment, finance lease liabilities and finance lease liabilities-long-term on the Condensed Consolidated Balance Sheets. The Company recognizes a ROU asset and corresponding lease obligation liability at the lease commencement date where the lease obligation liability is measured at the present value of the minimum lease payments. As most of the leases do not provide an implicit rate, the Company uses its incremental borrowing rate at lease commencement. The Company uses an interest rate commensurate with the interest rate to borrow on a collateralized basis over a similar term with an amount equal to the lease payments. Operating leases are primarily related to offices, research and development facilities, sales and marketing facilities, and manufacturing facilities. In addition, long-term supply agreements to lease gas tank equipment and purchase industrial gases are accounted for as operating leases. Lease agreements frequently include renewal provisions and require the Company to pay real estate taxes, insurance and maintenance costs. For operating leases, the amortization of the ROU asset and the accretion of its lease obligation liability result in a single straight-line expense recognized over the lease term. The finance lease is related to the $5.1 million of a machinery lease financing with a vendor. In September 2022, the lease was amended to make a monthly payment of principal and interest as a fixed amount effective in October 2022. Other terms remain the same. The amendment was accounted for as a debt modification and no gain or loss was recognized. In addition, the finance lease related to the RMB 400.0 million of lease financing of the JV Company with YinHai Leasing Company and The Export-Import Bank of China was not included in the Company’s unaudited Condensed Consolidated Balance Sheet at March 31, 2023 due to the deconsolidation of the JV Company on December 2, 2021. The Company does not record leases on the Condensed Consolidated Balance Sheets with a term of one year or less. The Company’s unaudited Condensed Consolidated Statements of Income for the nine months ended March 31, 2022 include the JV Company's results for the period preceding the deconsolidation on December 2, 2021. The components of the Company’s operating and finance lease expenses are as follows for the periods presented (in thousands): Three Months Ended March 31, Nine Months Ended March 31, 2023 2022 2023 2022 Operating leases: Fixed rent expense $ 1,385 $ 1,479 $ 4,298 $ 4,955 Variable rent expense 279 126 757 741 Finance lease: Amortization of equipment 128 15 393 787 Interest 83 11 227 692 Short-term leases Short-term lease expenses 133 38 300 144 Total lease expenses $ 2,008 $ 1,669 $ 5,975 $ 7,319 Supplemental balance sheets information related to the Company’s operating and finance leases is as follows (in thousands, except lease term and discount rate): March 31, June 30, Operating Leases : ROU assets associated with operating leases $ 22,962 $ 23,674 Finance Lease: Property, plant and equipment, gross $ 5,133 $ 4,831 Accumulated depreciation (529) (136) Property, plant and equipment, net $ 4,604 $ 4,695 Weighted average remaining lease term (in years) Operating leases 6.65 7.42 Finance lease 4.50 5.00 Weighted average discount rate Operating leases 4.39 % 4.27 % Finance lease 7.51 % 4.76 % Supplemental cash flow information related to the Company’s operating and finance lease is as follows (in thousands): Nine Months Ended March 31, 2023 2022 Cash paid from amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 4,418 $ 4,965 Operating cash flows from finance lease $ 227 $ 421 Financing cash flows from finance lease $ 603 $ 4,176 Non-cash investing and financing information: Operating lease right-of-use assets obtained in exchange for lease obligations $ 2,859 $ 5,901 Future minimum lease payments are as follows as of March 31, 2023 (in thousands): Year ending June 30, Operating Leases Finance Leases The remainder of fiscal 2023 $ 1,481 $ 286 2024 5,006 1,144 2025 4,133 1,144 2026 3,441 1,144 2027 3,264 1,145 Thereafter 10,301 191 Total minimum lease payments 27,626 5,054 Less amount representing interest (3,837) (764) Total lease liabilities $ 23,789 $ 4,290 |
Shareholders' Equity and Share-
Shareholders' Equity and Share-based Compensation | 9 Months Ended |
Mar. 31, 2023 | |
Share-Based Payment Arrangement, Noncash Expense [Abstract] | |
Shareholders' Equity and Share-based Compensation | Shareholders' Equity and Share-based Compensation Share Repurchase In September 2017, the Board of Directors approved a repurchase program (the “Repurchase Program”) that allowed the Company to repurchase its common shares from the open market pursuant to a pre-established Rule 10b5-1 trading plan or through privately negotiated transactions up to an aggregate of $30.0 million. The amount and timing of any repurchases under the Repurchase Program depend on a number of factors, including but not limited to, the trading price, volume and availability of the Company’s common shares. Shares repurchased under this program are accounted for as treasury shares and the total cost of shares repurchased is recorded as a reduction of shareholders' equity. From time to time, treasury shares may be reissued as part of the Company’s share-based compensation programs. Gains on re-issuance of treasury stock are credited to additional paid-in capital; losses are charged to additional paid-in capital to offset the net gains, if any, from previous sales or re-issuance of treasury stock. Any remaining balance of the losses is charged to retained earnings. During the three months ended March 31, 2023, the Company repurchased an aggregate of 106,863 shares from the open market, for a total cost of $2.7 million, excluding fees and related expenses, at an average price of $24.9 per share. Since the inception of the program, the Company repurchased an aggregate of 6,891,511 shares for a total cost of $70.0 million, at an average price of $10.16 per share, excluding fees and related expenses. No repurchased shares have been retired. Of the 6,891,511 repurchased shares, 174,724 shares with a weighted average repurchase price of $9.98 per share, were reissued at an average price of $4.79 per share pursuant to option exercises and vested restricted share units (“RSU”). As of March 31, 2023, approximately $10.8 million remained available under the Repurchase Program. Time-based Restric ted Stock Units ( “ TRSU ” ) The following table summarizes the Company's TRSU activities for the nine months ended March 31, 2023: Number of Restricted Stock Weighted Average Weighted Average Aggregate Intrinsic Value Nonvested at June 30, 2022 1,169,609 $ 34.03 1.73 $ 38,994,764 Granted 625,080 $ 28.14 Vested (418,269) $ 28.90 Forfeited (35,025) $ 31.34 Nonvested at March 31, 2023 1,341,395 $ 32.96 1.89 $ 36,150,595 Market-based Restricted Stock Units ( “ MSU ” ) In December 2021, the Company granted 1.0 million market-based restricted stock units ("MSUs") to certain personnel. The number of shares to be earned at the end of performance period is determined based on the Company’s achievement of specified stock prices and revenue thresholds during the performance period from January 1, 2022 to December 31, 2024 as well as the recipients remaining in continuous service with the Company through such period. The MSU vests in four equal annual installments after the end of performance period. The Company estimated the grant date fair values of its MSU with derived service periods of 4.1 to 7.1 years using a Monte-Carlo simulation model with the following assumptions: Risk-free interest rate of 1.0%, expected term of 3.1 years, expected volatility of 62.8% and dividend yield of 0%. The Company recorded $2.1 million and $6.2 million of expenses for these MSUs during the three and nine months ended March 31, 2023, respectively, and $2.0 million and $2.5 million of expenses during the three and nine months ended March 31, 2022. During the quarter ended September 30, 2018, the Company granted 1.3 million MSUs to certain personnel. The number of shares to be earned at the end of performance period is determined based on the Company’s achievement of specified stock prices and revenue thresholds during the performance period from January 1, 2019 to December 31, 2021 as well as the recipients remaining in continuous service with the Company through such period. The MSUs vest in four equal annual installments after the end of the performance period. The Company estimated the grant date fair values of its MSUs using a Monte-Carlo simulation model. On August 31, 2020, the Compensation Committee of the Board approved a modification of the terms of MSU to (i) extend the performance period through December 31, 2022 and (ii) change the commencement date for the four-year time-based service period to January 1, 2023. The fair value of these MSUs was recalculated to reflect the change as of August 31, 2020 and the unrecognized compensation amount was adjusted to reflect the increase in fair value. The Company recorded $0.3 million and $3.6 million of expenses for MSUs during the three and nine months ended March 31, 2023, respectively, and $0.4 million and $1.2 million of expenses for MSUs during the three and nine months ended March 31, 2022, respectively. Performance-based Restricted Stock Units (“PRSUs”) In March each year since year 2017, the Company granted PRSUs to certain personnel. The number of shares to be earned under the PRSUs is determined based on the level of attainment of predetermined financial goals. The PRSUs vest in four equal annual installments from the first anniversary date after the grant date if certain predetermined financial goals were met. The Company recorded approximately $1.4 million and $4.1 million of e xpens e for these PRSUs during the three and nine months ended March 31, 2023, respectively, and approximately $1.0 million and $3.0 million during the three and nine months ended March 31, 2022. The following table summarizes the Company’s PRSUs activities for the nine months ended March 31, 2023: Number of Performance-based Restricted Stock Weighted Average Weighted Average Aggregate Intrinsic Value Nonvested at June 30, 2022 389,375 $ 36.56 1.85 $ 12,981,763 Granted 264,214 $ 25.70 Vested (116,132) $ 30.54 Forfeited (10,743) $ 48.65 Nonvested at March 31, 2023 526,714 $ 32.19 2.03 $ 14,194,942 Stock Options The Company did not grant any stock options during the nine months ended March 31, 2023 and 2022. The following table summarizes the Company's stock option activities for the nine months ended March 31, 2023: Weighted Weighted Average Average Remaining Number of Exercise Price Contractual Aggregate Shares Per Share Term (in years) Intrinsic Value Outstanding at June 30, 2022 389,875 $ 7.70 1.53 $ 9,997,364 Exercised (65,500) $ 8.42 $ 1,442,646 Outstanding at March 31, 2023 324,375 $ 7.55 0.96 $ 6,292,088 Options vested and expected to vest 324,375 $ 7.55 0.96 $ 6,292,088 Exercisable at March 31, 2023 324,375 $ 7.55 0.96 $ 6,292,088 Employee Share Purchase Plan (“ESPP”) The assumptions used to estimate the fair values of common shares issued under the ESPP were as follows: Nine Months Ended March 31, 2023 Volatility rate 70.5% Risk-free interest rate 4.5% Expected term 1.3 years Dividend yield 0% Share-based Compensation Expense On September 8, 2022, the Compensation Committee of the Board approved modifications to the terms of equity awards granted to a former officer who was a board member of the Company. The modifications waived the four-year time based service performance of his MSU allowing continuing vesting of his TRSU and PRSU according to the original awards' vesting schedule after his termination as a board member. The incremental expenses for these equity shares resulting from the modification were $3.9 million. During the three and nine months ended March 31, 2023, the Company recorded nil and $3.1 million, respectively, net of reversal of prior recorded expenses, of shared-based compensation for these equity shares. The total share-based compensation expense recognized in the Condensed Consolidated Statements of Income for the periods presented was as follows: Three Months Ended March 31, Nine Months Ended March 31, 2023 2022 2023 2022 (in thousands) (in thousands) Cost of goods sold $ 1,723 $ 1,282 $ 5,259 $ 3,560 Research and development 2,987 1,814 8,808 4,769 Selling, general and administrative 5,722 5,177 20,052 13,125 $ 10,432 $ 8,273 $ 34,119 $ 21,454 As of March 31, 2023, total unrecognized compensation cost under the Company's equity plans was $77.5 million, which is expected to be recognized over a weighted-average period of 2.8 years. |
Income Taxes
Income Taxes | 9 Months Ended |
Mar. 31, 2023 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | Income Taxes The Company recognized income tax expense of approximately $2.5 million and $2.9 million for the three months ended March 31, 2023 and 2022, respectively. The income tax expense of $2.5 million for the three months ended March 31, 2023 included a $0.03 million discrete tax expense. The income tax expense of $2.9 million for the three months ended March 31, 2022 included a $0.7 million discrete tax expense related to the Company’s $4.5 million of gain related to the revaluation of the Company's equity interest in a joint venture. Excluding the discrete income tax items, the income tax expense for the three months ended March 31, 2023 and 2022 was $2.5 million and $2.2 million, respectively, and the effective tax rate for the three months ended March 31, 2023 and 2022 was (15.2)% and 7.4%, respectively. Excluding the effects of the discrete tax expense recorded in the three months ended March 31, 2023 and 2022, the changes in the tax expense and effective tax rate between the periods resulted primarily from changes in the mix of earnings in various geographic jurisdictions between the current year and the same period of last year as well as from reporting pretax book loss of $16.4 million for the three months ended March 31, 2023 as compared to $30.0 million of pretax book income (excluding the $4.5 million of gain related ot the revaluation of the Company's equity interest in a joint venture) for the three months ended March 31, 2022. The Company recognized income tax expense of approximately $5.6 million and $38.3 million for the nine months ended March 31, 2023 and 2022, respectively. The income tax expense of $5.6 million for the nine months ended March 31, 2023 included a $0.1 million discrete tax expense. The income tax expense of $38.3 million for the nine months ended March 31, 2022 included a $33.5 million discrete tax expense related to the Company’s $396.0 million of income from the sale of equity interest in a joint venture and the related deconsolidation gain as the Company switches from the consolidation method of accounting to the equity method of accounting related to this investment and no longer asserts permanent reinvestment related to the Company’s investment in the joint venture as well as $0.1 million for other discrete income tax items. Excluding the discrete income tax items, income tax expense for the nine months ended March 31, 2023 and 2022 was $5.4 million and $4.7 million, respectively, and the effective tax rate for the nine months ended March 31, 2023 and 2022 was 28.4% and 6.0%, respectively. Excluding the effects of the discrete tax expense recorded in the nine months ended March 31, 2023 and 2022, the changes in the tax expense and effective tax rate between the periods resulted primarily from changes in the mix of earnings in various geographic jurisdictions between the current year and the same period of last year as well as from the Company reporting a pretax book income of $19.0 million for the nine months ended March 31, 2023 as compared to pretax book income of $80.4 million of pretax book income (excluding the $396.0 million of income from the sale of equity interest in a joint venture and the related deconsolidation gain) for the nine months ended March 31, 2022. The Company files its income tax returns in the United States and in various foreign jurisdictions. The tax years 2001 to 2022 remain open to examination by U.S. federal and state tax authorities. The tax years 2014 to 2022 remain open to examination by foreign tax authorities. The Company's income tax returns are subject to examinations by the Internal Revenue Service and other tax authorities in various jurisdictions. In accordance with the guidance on the accounting for uncertainty in income taxes, the Company regularly assesses the likelihood of adverse outcomes resulting from these examinations to determine the adequacy of its provision for income taxes. These assessments can require considerable estimates and judgments. As of March 31, 2023, the gross amount of unrecognized tax benefits was approximately $8.7 million, of which $5.7 million, if recognized, would reduce the effective income tax rate in future periods. If the Company's estimate of income tax liabilities proves to be less than the ultimate assessment, then a further charge to expense would be required. If events occur and the payment of these amounts ultimately proves to be unnecessary, the reversal of the liabilities would result in tax benefits being recognized in the period when the Company determines the liabilities are no longer necessary. The Company does not anticipate any material changes to its uncertain tax positions during the next twelve months. “The Chip and Science Act of 2022”, Enacted August 2, 2022 In August 2022 the U.S. enacted the Chip and Science Act of 2022 (the Chips Act). The Chips Act provides incentives to semiconductor chip manufacturers in the United States, including providing a 25% manufacturing investment credits for investments in semiconductor manufacturing property placed in service after December 31, 2022, for which construction begins before January 1, 2027. Property investments qualify for the 25% credit if, among other requirements, the property is integral to the operation of an advanced manufacturing facility, defined as having a primary purpose of manufacturing semiconductors or semiconductor manufacturing equipment. Currently, we are evaluating the impact of the Chips Act to us. “The Inflation Reduction Act”, Enacted August 16, 2022 In August 2022 the United States enacted tax legislation through the Inflation Reduction Act (IRA). The IRA introduces a 15% corporate alternative minimum tax (CAMT) for corporations whose average annual adjusted financial statement income (AFSI) for any consecutive three-tax-year period preceding the applicable tax year exceeds $1 billion. The CAMT is effective for tax years beginning after December 31, 2022. The CAMT is currently not applicable to the Company. Altera Litigation On July 27, 2015, in Altera Corp. v. Commissioner, the U.S. Tax Court issued an opinion related to the treatment of stock-based compensation expense in an intercompany cost-sharing arrangement. In the July 2015 ruling, the Tax Court concluded that the sharing of the cost of employee stock compensation in a company’s cost-sharing arrangement was invalid under the U.S. Administrative Procedures Act. In June 2019, a panel of the Ninth Circuit of the U.S. Court of Appeals reversed this decision. In July 2019, Altera petitioned U.S. Court of Appeals for the Ninth Circuit to hold an en banc rehearing of the case. The petition was subsequently denied by the Ninth Circuit. Altera appealed the case to the U.S. Supreme Court in February 2020, but the U.S. Supreme Court declined to hear the case in June 2020, leaving intact the U.S. Court of Appeals for the Ninth Circuit’s decision. AOS has not recorded any benefit related to the Altera Corporation Tax Court decision in any period through December 2022. The Company will continue to monitor ongoing developments and potential impact to its financial statements. |
Segment and Geographic Informat
Segment and Geographic Information | 9 Months Ended |
Mar. 31, 2023 | |
Segment Reporting [Abstract] | |
Segment and Geographic Information | Segment and Geographic Information The Company is organized as, and operates in, one operating segment: the design, development and supply of power semiconductor products for computing, consumer electronics, communication and industrial applications. The chief operating decision-makers are the Executive Chairman and the Chief Executive Officer. The financial information presented to the Company’s Executive Chairman and Chief Executive Officer is on a consolidated basis, accompanied by information about revenue by customer and geographic region, for purposes of evaluating financial performance and allocating resources. The Company has one business segment, and there are no segment managers who are held accountable for operations, operating results and plans for products or components below the consolidated unit level. Accordingly, the Company reports as a single operating segment. The Company sells its products primarily to distributors in the Asia Pacific region, who in turn sell these products to end customers. Because the Company’s distributors sell their products to end customers which may have a global presence, revenue by geographical location is not necessarily representative of the geographical distribution of sales to end user markets. In February 2023, the Company entered into a license agreement with a customer to license the Company’s proprietary SiC technology and to provide 24-month engineering and development services for a total fee of $45 million. The revenue by geographical location in the following tables is based on the country or region in which the products were shipped to: Three Months Ended March 31, Nine Months Ended March 31, 2023 2022 2023 2022 (in thousands) (in thousands) Hong Kong $ 106,940 $ 164,555 $ 438,537 $ 472,399 China 14,360 31,883 58,104 91,958 South Korea 1,083 2,745 7,622 8,862 United States 4,245 3,534 16,701 9,004 Other countries 5,932 522 8,832 1,370 $ 132,560 $ 203,239 $ 529,796 $ 583,593 The Company has classified certain amounts previously reported in revenue of power discrete and power IC to conform to the current presentation. The following is a summary of revenue by product type: Three Months Ended March 31, Nine Months Ended March 31, 2023 2022 2023 2022 (in thousands) (in thousands) Power discrete $ 80,962 $ 140,027 $ 363,117 $ 404,902 Power IC 47,416 60,904 159,708 169,115 Packaging and testing services 552 2,308 3,341 9,576 License and development services 3,630 — 3,630 — $ 132,560 $ 203,239 $ 529,796 $ 583,593 Long-lived assets, net consisting of property, plant and equipment and operating lease right-of-use assets, net by geographical area are as follows: March 31, June 30, (in thousands) China $ 115,944 $ 105,326 United States 261,142 232,731 Other countries 4,033 4,283 $ 381,119 $ 342,340 |
Commitments and Contingencies
Commitments and Contingencies | 9 Months Ended |
Mar. 31, 2023 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | Commitments and Contingencies Purchase Commitments As of March 31, 2023 and June 30, 2022, the Company had approximately $120.6 million and $89.9 million, respectively, of outstanding purchase commitments primarily for purchases of semiconductor raw materials, wafers, spare parts, packaging and testing services and others. As of March 31, 2023 and June 30, 2022, the Company had approximately $11.9 million and $63.4 million, respectively, of capital commitments for the purchase of property and equipment. Other Commitments See Note 7 and Note 8 of the Notes to the Condensed Consolidated Financial Statements contained in this Quarterly Report on Form 10-Q for descriptions of commitments including bank borrowings and leases. Contingencies and Indemnities The Company has in the past, and may from time to time in the future, become involved in legal proceedings arising from the normal course of business activities. The semiconductor industry is characterized by frequent claims and litigation, including claims regarding patent and other intellectual property rights as well as improper hiring practices. Irrespective of the validity of such claims, the Company could incur significant costs in the defense of such claims and suffer adverse effects on its operations. In December 2019, the U.S. Department of Justice (“DOJ”) commenced an investigation into the Company's compliance with export control regulations relating to its business transactions with Huawei and its affiliates (“Huawei”), which were added to the “Entity List” maintained by the Department of Commerce (“DOC”) on May 16, 2019. The Company is cooperating fully with federal authorities in the investigation, including responding to requests for documents, information and interviews from DOJ in connection with the investigation. The Company has maintained an export control compliance program and has been committed to comply fully with all applicable laws and regulations. In connection with this investigation, DOC requested the Company to suspend shipments of its products to Huawei, and the Company complied with such request, and the Company has not shipped any product to Huawei after December 31, 2019. The Company is currently working with DOC to resolve this issue. Given the case is in still ongoing and neither DOJ nor DOC have provided the Company with any clear indication of the timing and schedule for the investigation, the Company cannot estimate the reasonably possible loss or range of loss that may occur. Also, the Company is unable to predict the duration, scope, result or related costs of the investigation, although the Company expects to incur additional professional fees as a result of this matter. In addition, the Company is unable to predict what, if any, further action that may be taken by the government in connection with the investigation, or what, if any, penalties, sanctions or remedial actions may be sought. The Company is a party to a variety of agreements that it has contracted with various third parties. Pursuant to these agreements, the Company may be obligated to indemnify another party to such an agreement with respect to certain matters. Typically, these obligations arise in the context of contracts entered into by the Company, under which the Company customarily agrees to hold the other party harmless against losses arising from a breach of representations and covenants related to such matters as title to assets sold, certain intellectual property rights, specified environmental matters and certain income taxes. In these circumstances, payment by the Company is customarily conditioned on the other party making a claim pursuant to the procedures specified in the particular contract, which procedures typically allow the Company to challenge the other party's claim. Further, the Company's obligations under these agreements may be limited in time and/or amount, and in some instances, the Company may have recourse against third parties for certain payments made by it under these agreements. The Company has not historically paid or recorded any material indemnifications, and no accrual was made at March 31, 2023 and June 30, 2022. The Company has agreed to indemnify its directors and certain employees as permitted by law and pursuant to its Bye-laws, and has entered into indemnification agreements with its directors and executive officers. The Company has not recorded a liability associated with these indemnification arrangements, as it historically has not incurred any material costs associated with such indemnification obligations. Costs associated with such indemnification obligations may be mitigated by insurance coverage that the Company maintains. However, such insurance may not cover any, or may cover only a portion of, the amounts the Company may be required to pay. In addition, the Company may not be able to maintain such insurance coverage at reasonable cost, if at all, in the future. |
The Company and Significant A_2
The Company and Significant Accounting Policies (Policies) | 9 Months Ended |
Mar. 31, 2023 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Basis of Preparation | Basis of Preparation The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) for interim financial information and with the instructions to Article 10 of Securities and Exchange Commission Regulation S-X, as amended. They do not include all information and footnotes necessary for a fair presentation of financial position, results of operations and cash flows in conformity with U.S. GAAP for complete financial statements. These Condensed Consolidated Financial Statements should be read in conjunction with the consolidated financial statements and related notes contained in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2022. All significant intercompany balances and transactions have been eliminated in consolidation. In the opinion of management, all adjustments (consisting of normal recurring adjustments and accruals) considered necessary for a fair presentation of the results of operations for the periods presented have been included in the interim periods. Operating results for the nine months ended March 31, 2023 are not necessarily indicative of the results that may be expected for the fiscal year ending June 30, 2023 or any other interim period. The consolidated balance sheet at June 30, 2022 is derived from the audited financial statements included in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2022. |
Risks and Uncertainties | Certain Significant Risks and Uncertainties Related to Outbreak of Coronavirus Disease 2019 (“COVID-19”) During the first half of calendar year 2022, the Company's operations were negatively impacted by China’s zero-Covid policy that resulted in factory shutdowns and supply chain shortages, including the temporary suspension of its factory operations in Shanghai from April to June 2022. In December 2022, the Chinese government issued new guidelines easing some of its strict zero-COVID policies, including the relaxation of testing requirements and travel restrictions. The change of |
Use of Estimates | Use of Estimates The preparation of the consolidated financial statements in conformity with U.S. GAAP requires the Company to make estimates, judgments and assumptions that affect the reported amounts of assets, liabilities, revenue and expenses. To the extent there are material differences between these estimates and actual results, the Company's condensed consolidated financial statements will be affected. On an ongoing basis, the Company evaluates the estimates, judgments and assumptions including those related to stock rotation returns, price adjustments, allowance for doubtful accounts, inventory reserves, warranty accrual, income taxes, leases, share-based compensation, recoverability of and useful lives for property, plant and equipment and intangible assets, as well as the economic implications of the COVID-19 pandemic. |
Leases | Leases The Company determines if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (“ROU”) assets, current operating lease liabilities and long-term operating lease liabilities on the Company's Condensed Consolidated Balance Sheets. Finance leases are included in property, plant and equipment, finance lease liabilities and long-term finance leases liabilities on the Condensed Consolidated Balance Sheets. Operating lease ROU assets and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. The Company uses an estimate of its incremental borrowing rate based on the information available at the lease commencement date. The operating lease ROU assets also include any lease payments made and exclude lease incentives. Lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise such options. Operating lease expense is generally recognized on a straight-line basis over the lease term. Variable lease payments are expensed as incurred and are not included within the operating lease ROU asset and lease liability calculation. The Company does not record leases on the Condensed Consolidated Balance Sheet with a term of one year or less. The Company elected to combine its lease and non-lease components as a single lease component for all asset classes. |
Revenue recognition | Revenue recognition The Company determines revenue recognition through the following steps: (1) identification of the contract with a customer; (2) identification of the performance obligations in the contract; (3) determination of the transaction price; (4) allocation of the transaction price to the performance obligations in the contract; and (5) recognition of revenue when, or as, a performance obligation is satisfied. The Company recognizes product revenue at a point in time when product is shipped to the customer, net of estimated stock rotation returns and price adjustments that it expects to provide to certain distributors. The Company presents revenue net of sales taxes and any similar assessments. Our standard payment terms range from 30 to 60 days. The Company sells its products primarily to distributors, who in turn sell the products globally to various end customers. The Company allows stock rotation returns from certain distributors. Stock rotation returns are governed by contract and are limited to a specified percentage of the monetary value of products purchased by distributors during a specified period. The Company records an allowance for stock rotation returns based on historical returns and individual distributor agreements. The Company also provides special pricing to certain distributors, primarily based on volume, to encourage resale of the Company’s products. Allowance for price adjustments is recorded against accounts receivable and the provision for stock rotation rights is included in accrued liabilities on the Condensed Consolidated Balance Sheets. The Company’s performance obligations relate to contracts with a duration of less than one year. The Company elected to apply the practical expedient provided in ASC 606, “Revenue from Contracts with Customers”. Therefore, the Company is not required to disclose the aggregate amount of transaction price allocated to performance obligations that are unsatisfied or partially unsatisfied at the end of the reporting period. The Company recognizes the incremental direct costs of obtaining a contract, which consist of sales commissions, when control over the products they relate to transfers to the customer. Applying the practical expedient, the Company recognizes commissions as expense when incurred, as the amortization period of the commission asset the Company would have otherwise recognized is less than one year. |
Share-based Compensation Expense | Share-based Compensation Expense The Company maintains an equity-settled, share-based compensation plan to grant restricted share units and stock options. The Company recognizes expense related to share-based compensation awards that are ultimately expected to vest based on estimated fair values on the date of grant. The fair value of restricted share units is based on the fair value of the Company's common share on the date of grant. For restricted stock awards subject to market conditions, the fair value of each restricted stock award is estimated at the date of grant using the Monte-Carlo pricing model. The fair value of stock options is estimated on the date of grant using the Black-Scholes option valuation model. Share-based compensation expense is recognized on the accelerated attribution basis over the requisite service period of the award, which generally equals the vesting period. The Employee Share Purchase Plan (the “ESPP”) is accounted for at fair value on the date of grant using the Black-Scholes option valuation model. |
Restricted Cash | Restricted CashThe Company maintains restricted cash in connection with cash balances temporarily restricted for regular business operations. These balances have been excluded from the Company’s cash and cash equivalents balance and are classified as restricted cash in the Company’s Condensed Consolidated Balance Sheets. |
Fair Value of Financial Instruments | Fair Value of Financial Instruments The fair value of cash equivalents is categorized in Level 1 in the fair value hierarchy. Cash equivalents consist primarily of short-term bank deposits. The carrying values of financial instruments such as cash and cash equivalents, accounts receivable and accounts payable approximate their carrying values due to their short-term maturities. The carrying value of the Company's debt is considered a reasonable estimate of fair value which is estimated by considering the current rates available to the Company for debt of the same remaining maturities, structure, credit risk and terms of the debts. |
Government Grants | Government GrantsThe Company occasionally receives government grants that provide financial assistance for certain eligible expenditures in China. These grants include reimbursements on interest expense on bank borrowings, payroll tax credits, credit for property, plant and equipment in a particular geographical location, employment credits, as well as business expansion credits. Government grants are not recognized until there is reasonable assurance that the Company will comply with the conditions attaching to it, and that the grant will be received. The Company records such grants either as a reduction of the related expense, a reduction of the cost of the related asset, or as other income depending upon the nature of the grant. |
Accounting for income taxes | Accounting for income taxes Income tax expense or benefit is based on income or loss before income taxes. Deferred tax assets and liabilities are recognized principally for the expected tax consequences of temporary differences between the tax basis of assets and liabilities and their reported amounts. The Company is subject to income taxes in a number of jurisdictions. Significant judgment is required in determining the worldwide provision for income taxes. There are many transactions and calculations for which the ultimate tax determination is uncertain during the ordinary course of business. The Company establishes accruals for certain tax contingencies based on estimates of whether additional taxes may be due. While the final tax outcome of these matters may differ from the amounts that were initially recorded, such differences will impact the income tax and deferred tax provisions in the period in which such determination is made. Significant management judgment is also required in determining whether deferred tax assets will be realized in full or in part. When it is more likely than not that all or some portion of specific deferred tax assets such as net operating losses or research and development tax credit carryforwards will not be realized, a valuation allowance must be established for the amount of the deferred tax assets that cannot be realized. The Company considers all available positive and negative evidence on a jurisdiction-by-jurisdiction basis when assessing whether it is more likely than not that deferred tax assets are recoverable. The Company considers evidence such as our past operating results, the existence of cumulative losses in recent years and our forecast of future taxable income. The Financial Accounting Standards Board (FASB), issued guidance which clarifies the accounting for income taxes by prescribing a minimum probability threshold that a tax position must meet before a financial statement benefit is recognized. The minimum threshold is defined as a tax position that is more likely than not to be sustained upon examination by the applicable taxing authority, including resolution of any related appeals or litigation processes, based on the technical merits of the position. The tax benefit to be recognized is measured as the largest amount of benefit that is greater than fifty percent likely to be realized upon ultimate settlement. Although the guidance on the accounting for uncertainty in income taxes prescribes the use of a recognition and measurement model, the determination of whether an uncertain tax position has met those thresholds will continue to require significant judgment by management. If the ultimate resolution of tax uncertainties is different from what is currently estimated, a material impact on income tax expense could result. The Company's provision for income taxes is subject to volatility and could be adversely impacted by changes in earnings or tax laws and regulations in various jurisdictions. The Company is subject to the continuous examination of our income tax returns by the Internal Revenue Service and other tax authorities. The Company regularly assesses the likelihood of adverse outcomes resulting from these examinations to determine the adequacy of our provision for income taxes. To the extent that the final tax outcome of these matters is different from the amounts recorded, such differences will impact the provision for income taxes in the period in which such determination is made. The provision for income taxes includes the impact of changes to reserves, as well as the related net interest and penalties. |
Long-lived Assets | Long-lived Assets The Company reviews all long-lived assets whenever events or changes in circumstance indicate that these assets may not be recoverable. When evaluating long-lived assets, if the Company concludes that the estimated undiscounted cash flows attributable to the assets are less than their carrying value, the Company recognizes an impairment loss based on the excess of the carrying amount of the assets over their respective fair values, which could adversely affect its results of operations. |
Comprehensive Income | Comprehensive Income Comprehensive income is defined as the change in equity of a business enterprise during a period from transactions and other events and circumstances from non-owner sources. The Company's accumulated other comprehensive income consists of cumulative foreign currency translation adjustments. Total comprehensive income is presented in the Condensed Consolidated Statements of Comprehensive Income. |
Recent Accounting Pronouncements | Recent Accounting Pronouncements Recently Issued Accounting Standards not yet adopted In September 2022, the FASB issued ASU No. 2022-04, "Liabilities - Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations". This ASU was issued in response to requests from financial statement users for increased transparency surrounding the use of supplier finance programs. The amendments in ASU 2022-04 require that a buyer in a supplier finance program disclose sufficient information about the program to allow a user of financial statements to understand the program’s nature, activity during the period, changes from period to period, and potential magnitude. The amendments in this ASU do not affect the recognition, measurement, or financial statement presentation of obligations covered by supplier finance programs. The amendments in this ASU are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, except for the amendment on rollforward information, which is effective for fiscal years beginning after December 15, 2023. Early adoption is permitted. The Company is currently evaluating the impact of adopting this guidance. Recently Adopted Accounting Standards In November 2021, the FASB issued Accounting Standards Update (ASU) No. 2021-10, Government Assistance (Topic 832): Disclosures by Business Entities about Government Assistance. This ASU requires business entities to make annual disclosures about transactions with a government they account for by analogizing to a grant or contribution accounting model under ASC 958-605. The adoption of ASU 2021-10 had no impact on the Company's Consolidated Financial Statements. In August 2020, the FASB issued ASU No. 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity, which, among other things, provides guidance on how to account for contracts on an entity’s own equity. This ASU simplifies the accounting for certain financial instruments with characteristics of liabilities and equity. Specifically, the ASU eliminated the need for the Company to assess whether a contract on the entity’s own equity (1) permits settlement in unregistered shares, (2) whether counterparty rights rank higher than shareholder’s rights, and (3) whether collateral is required. In addition, the ASU requires incremental disclosure related to contracts on the entity’s own equity and clarifies the treatment of certain financial instruments accounted for under this ASU on earnings per share. The adoption of ASU 2020-06 had no impact on the Company's Consolidated Financial Statements. |
Concentration of Credit Risk | The Company manages its credit risk associated with exposure to distributors and direct customers on outstanding accounts receivable through the application and review of credit approvals, credit ratings and other monitoring procedures. In some instances, the Company also obtains letters of credit from certain customers. Credit sales, which are mainly on credit terms of 30 to 60 days, are only made to customers who meet the Company's credit requirements, while sales to new customers or customers with low credit ratings are usually made on an advance payment basis. The Company considers its trade accounts receivable to be of good credit quality because its key distributors and direct customers have long-standing business relationships with the Company and the Company has not experienced any significant bad debt write-offs of accounts receivable in the past. The Company closely monitors the aging of accounts receivable from its distributors and direct customers, and regularly reviews their financial positions, where available. |
Net Income (Loss) Per Common _2
Net Income (Loss) Per Common Share Attributable to Alpha and Omega Semiconductor Limited - (Tables) | 9 Months Ended |
Mar. 31, 2023 | |
Earnings Per Share [Abstract] | |
Schedule of Earnings Per Share, Basic and Diluted | The following table presents the calculation of basic and diluted net income (loss) per share attributable to common shareholders: Three Months Ended March 31, Nine Months Ended March 31, 2023 2022 2023 2022 (in thousands, except per share data) Numerator: Net income (loss) attributable to Alpha and Omega Semiconductor Limited $ (18,907) $ 31,650 $ 13,468 $ 438,072 Denominator: Basic: Weighted average number of common shares used to compute basic net income (loss) per share 27,710 26,829 27,537 26,596 Diluted: Weighted average number of common shares used to compute basic net income (loss) per share 27,710 26,829 27,537 26,596 Effect of potentially dilutive securities: Stock options, RSUs and ESPP shares — 1,594 2,039 1,520 Weighted average number of common shares used to compute diluted net income (loss) per share 27,710 28,423 29,576 28,116 Net income (loss) per share attributable to Alpha and Omega Semiconductor Limited: Basic $ (0.68) $ 1.18 $ 0.49 $ 16.47 Diluted $ (0.68) $ 1.11 $ 0.46 $ 15.58 |
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share | The following potential dilutive securities were excluded from the computation of diluted net income (loss) per share as their effect would have been anti-dilutive: Three Months Ended March 31, Nine Months Ended March 31, 2023 2022 2023 2022 (in thousands) (in thousands) Employee stock options and RSUs 3,152 2 281 171 ESPP 767 19 279 27 Total potential dilutive securities 3,919 21 560 198 |
Concentration of Credit Risk _2
Concentration of Credit Risk and Significant Customers (Tables) | 9 Months Ended |
Mar. 31, 2023 | |
Risks and Uncertainties [Abstract] | |
Schedules of Concentration of Risk, by Risk Factor | Summarized below are individual customers whose revenue or accounts receivable balances were 10% or higher than the respective total consolidated amounts: Three Months Ended March 31, Nine Months Ended March 31, Percentage of revenue 2023 2022 2023 2022 Customer A 21.0 % 24.2 % 21.7 % 24.8 % Customer B 28.7 % 38.8 % 35.5 % 38.7 % Customer C 17.9 % * 14.1 % * March 31, June 30, Percentage of accounts receivable Customer A * 24.6 % Customer B * 36.4 % Customer C 46.0 % 12.0 % Customer D 21.9 % * |
Balance Sheet Components (Table
Balance Sheet Components (Tables) | 9 Months Ended |
Mar. 31, 2023 | |
Balance Sheet Related Disclosures [Abstract] | |
Schedule of Accounts, Notes, Loans and Financing Receivable | Accounts receivable, net: March 31, June 30, (in thousands) Accounts receivable $ 54,269 $ 84,442 Less: Allowance for price adjustments (34,805) (18,731) Less: Allowance for doubtful accounts (30) (30) Accounts receivable, net $ 19,434 $ 65,681 |
Schedule of Inventory, Current | Inventories: March 31, June 30, (in thousands) Raw materials $ 86,490 $ 67,960 Work-in-process 69,905 80,720 Finished goods 23,388 9,360 $ 179,783 $ 158,040 |
Other Current Assets | Other current assets: March 31, June 30, (in thousands) Value-added tax receivable $ 179 $ 737 Other prepaid expenses 3,950 3,954 Prepaid insurance 751 2,590 Prepaid maintenance 1,092 826 Prepayment to supplier 71 257 Prepaid income tax 2,176 2,086 Interest receivable 172 25 Other receivables 1,578 745 $ 9,969 $ 11,220 |
Property, Plant and Equipment | Property, plant and equipment, net: March 31, June 30, (in thousands) Land $ 4,877 $ 4,877 Building 26,243 16,691 Manufacturing machinery and equipment 320,087 287,574 Equipment and tooling 31,428 28,052 Computer equipment and software 49,425 46,758 Office furniture and equipment 3,175 2,820 Leasehold improvements 38,051 35,254 473,286 422,026 Less: accumulated depreciation (261,814) (233,340) 211,472 188,686 Equipment and construction in progress 146,685 129,980 Property, plant and equipment, net $ 358,157 $ 318,666 |
Intangible Assets Disclosure | Intangible assets, net: March 31, June 30, (in thousands) Patents and technology rights $ 18,037 $ 18,037 Trade name 268 268 Customer relationships 1,150 1,150 19,455 19,455 Less: accumulated amortization (12,147) (9,674) 7,308 9,781 Goodwill 269 269 Intangible assets, net $ 7,577 $ 10,050 |
Schedule Future Amortization Expense of Intangible Assets | Estimated future minimum amortization expense of intangible assets is as follows (in thousands): Year ending June 30, 2023 (Remaining) $ 812 2024 3,249 2025 3,247 $ 7,308 |
Schedule of Other Assets, Noncurrent | Other long-term assets: March 31, June 30, (in thousands) Prepayments for property and equipment $ 1,013 $ 6,890 Investment in a privately held company 100 100 Customs deposit 2,118 1,708 Deposit with supplier 13,040 6,396 Other long-term deposits 33 18 Office leases deposits 1,243 1,012 Other 3,111 1,553 $ 20,658 $ 17,677 |
Schedule of Accrued Liabilities | Accrued liabilities: March 31, June 30, (in thousands) Accrued compensation and benefits $ 18,750 $ 34,681 Warranty accrual 3,815 2,650 Stock rotation accrual 4,081 4,798 Accrued professional fees 2,407 2,659 Accrued inventory 1,322 2,491 Accrued facilities related expenses 2,285 2,421 Accrued property, plant and equipment 6,531 20,485 Other accrued expenses 4,160 5,159 Customer deposits 43,314 40,578 ESPP payable 3,364 971 $ 90,029 $ 116,893 |
Schedule of Product Warranty Liability | The activities in the warranty accrual, included in accrued liabilities, are as follows: Nine Months Ended March 31, 2023 2022 (in thousands) Beginning balance $ 2,650 $ 2,795 Additions 2,915 949 Utilization (1,750) (1,261) Ending balance $ 3,815 $ 2,483 |
Stock Rotation Accrual | The activities in the stock rotation accrual, included in accrued liabilities, are as follows: Nine Months Ended March 31, 2023 2022 (in thousands) Beginning balance $ 4,798 $ 3,917 Additions 9,187 3,030 Utilization (9,904) (2,740) Ending balance $ 4,081 $ 4,207 |
Other Long-Term Liabilities | Other long-term liabilities: March 31, June 30, (in thousands) Customer deposits $ 51,926 $ 70,301 Computer software liabilities 5,773 8,302 Other long-term liabilities $ 57,699 $ 78,603 |
Bank Borrowing (Tables)
Bank Borrowing (Tables) | 9 Months Ended |
Mar. 31, 2023 | |
Debt Disclosure [Abstract] | |
Schedule of Maturities | Maturities of short-term debt and long-term debt were as follows (in thousands): Year ending June 30, 2023 (Remaining) $ 16,339 2024 11,472 2025 11,664 2026 11,871 2027 14,344 Thereafter 536 Total principal 66,226 Less: debt issuance costs (112) Total principal, less debt issuance costs $ 66,114 Short-term Debt Long-term Debt Total Principal amount $ 24,925 $ 41,301 $ 66,226 Less: debt issuance costs (48) (64) (112) Total debt, less debt issuance costs $ 24,877 $ 41,237 $ 66,114 |
Leases - (Tables)
Leases - (Tables) | 9 Months Ended |
Mar. 31, 2023 | |
Leases [Abstract] | |
Components of Operating and Finance Lease Costs | The components of the Company’s operating and finance lease expenses are as follows for the periods presented (in thousands): Three Months Ended March 31, Nine Months Ended March 31, 2023 2022 2023 2022 Operating leases: Fixed rent expense $ 1,385 $ 1,479 $ 4,298 $ 4,955 Variable rent expense 279 126 757 741 Finance lease: Amortization of equipment 128 15 393 787 Interest 83 11 227 692 Short-term leases Short-term lease expenses 133 38 300 144 Total lease expenses $ 2,008 $ 1,669 $ 5,975 $ 7,319 Supplemental cash flow information related to the Company’s operating and finance lease is as follows (in thousands): Nine Months Ended March 31, 2023 2022 Cash paid from amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 4,418 $ 4,965 Operating cash flows from finance lease $ 227 $ 421 Financing cash flows from finance lease $ 603 $ 4,176 Non-cash investing and financing information: Operating lease right-of-use assets obtained in exchange for lease obligations $ 2,859 $ 5,901 |
Schedule of Lease Assets and Liabilities | Supplemental balance sheets information related to the Company’s operating and finance leases is as follows (in thousands, except lease term and discount rate): March 31, June 30, Operating Leases : ROU assets associated with operating leases $ 22,962 $ 23,674 Finance Lease: Property, plant and equipment, gross $ 5,133 $ 4,831 Accumulated depreciation (529) (136) Property, plant and equipment, net $ 4,604 $ 4,695 Weighted average remaining lease term (in years) Operating leases 6.65 7.42 Finance lease 4.50 5.00 Weighted average discount rate Operating leases 4.39 % 4.27 % Finance lease 7.51 % 4.76 % |
Schedule of Operating Lease Future Minimum Lease Payments (Topic 842) | Future minimum lease payments are as follows as of March 31, 2023 (in thousands): Year ending June 30, Operating Leases Finance Leases The remainder of fiscal 2023 $ 1,481 $ 286 2024 5,006 1,144 2025 4,133 1,144 2026 3,441 1,144 2027 3,264 1,145 Thereafter 10,301 191 Total minimum lease payments 27,626 5,054 Less amount representing interest (3,837) (764) Total lease liabilities $ 23,789 $ 4,290 |
Schedule of Finance Lease Future Minimum Lease Payments (Topic 842) | Future minimum lease payments are as follows as of March 31, 2023 (in thousands): Year ending June 30, Operating Leases Finance Leases The remainder of fiscal 2023 $ 1,481 $ 286 2024 5,006 1,144 2025 4,133 1,144 2026 3,441 1,144 2027 3,264 1,145 Thereafter 10,301 191 Total minimum lease payments 27,626 5,054 Less amount representing interest (3,837) (764) Total lease liabilities $ 23,789 $ 4,290 |
Shareholders' Equity and Shar_2
Shareholders' Equity and Share-based Compensation (Tables) | 9 Months Ended |
Mar. 31, 2023 | |
Share-Based Payment Arrangement, Noncash Expense [Abstract] | |
Restricted Stock Units Activity | Time-based Restric ted Stock Units ( “ TRSU ” ) The following table summarizes the Company's TRSU activities for the nine months ended March 31, 2023: Number of Restricted Stock Weighted Average Weighted Average Aggregate Intrinsic Value Nonvested at June 30, 2022 1,169,609 $ 34.03 1.73 $ 38,994,764 Granted 625,080 $ 28.14 Vested (418,269) $ 28.90 Forfeited (35,025) $ 31.34 Nonvested at March 31, 2023 1,341,395 $ 32.96 1.89 $ 36,150,595 The following table summarizes the Company’s PRSUs activities for the nine months ended March 31, 2023: Number of Performance-based Restricted Stock Weighted Average Weighted Average Aggregate Intrinsic Value Nonvested at June 30, 2022 389,375 $ 36.56 1.85 $ 12,981,763 Granted 264,214 $ 25.70 Vested (116,132) $ 30.54 Forfeited (10,743) $ 48.65 Nonvested at March 31, 2023 526,714 $ 32.19 2.03 $ 14,194,942 |
Summary of Stock Option Activities | The following table summarizes the Company's stock option activities for the nine months ended March 31, 2023: Weighted Weighted Average Average Remaining Number of Exercise Price Contractual Aggregate Shares Per Share Term (in years) Intrinsic Value Outstanding at June 30, 2022 389,875 $ 7.70 1.53 $ 9,997,364 Exercised (65,500) $ 8.42 $ 1,442,646 Outstanding at March 31, 2023 324,375 $ 7.55 0.96 $ 6,292,088 Options vested and expected to vest 324,375 $ 7.55 0.96 $ 6,292,088 Exercisable at March 31, 2023 324,375 $ 7.55 0.96 $ 6,292,088 |
Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions | The assumptions used to estimate the fair values of common shares issued under the ESPP were as follows: Nine Months Ended March 31, 2023 Volatility rate 70.5% Risk-free interest rate 4.5% Expected term 1.3 years Dividend yield 0% |
Share-based Compensation, Allocation of Recognized Period Costs | Share-based Compensation Expense On September 8, 2022, the Compensation Committee of the Board approved modifications to the terms of equity awards granted to a former officer who was a board member of the Company. The modifications waived the four-year time based service performance of his MSU allowing continuing vesting of his TRSU and PRSU according to the original awards' vesting schedule after his termination as a board member. The incremental expenses for these equity shares resulting from the modification were $3.9 million. During the three and nine months ended March 31, 2023, the Company recorded nil and $3.1 million, respectively, net of reversal of prior recorded expenses, of shared-based compensation for these equity shares. The total share-based compensation expense recognized in the Condensed Consolidated Statements of Income for the periods presented was as follows: Three Months Ended March 31, Nine Months Ended March 31, 2023 2022 2023 2022 (in thousands) (in thousands) Cost of goods sold $ 1,723 $ 1,282 $ 5,259 $ 3,560 Research and development 2,987 1,814 8,808 4,769 Selling, general and administrative 5,722 5,177 20,052 13,125 $ 10,432 $ 8,273 $ 34,119 $ 21,454 |
Segment and Geographic Inform_2
Segment and Geographic Information (Tables) | 9 Months Ended |
Mar. 31, 2023 | |
Segment Reporting [Abstract] | |
Disaggregation of Revenue | The Company sells its products primarily to distributors in the Asia Pacific region, who in turn sell these products to end customers. Because the Company’s distributors sell their products to end customers which may have a global presence, revenue by geographical location is not necessarily representative of the geographical distribution of sales to end user markets. In February 2023, the Company entered into a license agreement with a customer to license the Company’s proprietary SiC technology and to provide 24-month engineering and development services for a total fee of $45 million. The revenue by geographical location in the following tables is based on the country or region in which the products were shipped to: Three Months Ended March 31, Nine Months Ended March 31, 2023 2022 2023 2022 (in thousands) (in thousands) Hong Kong $ 106,940 $ 164,555 $ 438,537 $ 472,399 China 14,360 31,883 58,104 91,958 South Korea 1,083 2,745 7,622 8,862 United States 4,245 3,534 16,701 9,004 Other countries 5,932 522 8,832 1,370 $ 132,560 $ 203,239 $ 529,796 $ 583,593 The Company has classified certain amounts previously reported in revenue of power discrete and power IC to conform to the current presentation. The following is a summary of revenue by product type: Three Months Ended March 31, Nine Months Ended March 31, 2023 2022 2023 2022 (in thousands) (in thousands) Power discrete $ 80,962 $ 140,027 $ 363,117 $ 404,902 Power IC 47,416 60,904 159,708 169,115 Packaging and testing services 552 2,308 3,341 9,576 License and development services 3,630 — 3,630 — $ 132,560 $ 203,239 $ 529,796 $ 583,593 |
Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas | Long-lived assets, net consisting of property, plant and equipment and operating lease right-of-use assets, net by geographical area are as follows: March 31, June 30, (in thousands) China $ 115,944 $ 105,326 United States 261,142 232,731 Other countries 4,033 4,283 $ 381,119 $ 342,340 |
The Company and Significant A_3
The Company and Significant Accounting Policies - Joint Venture (Details) | 9 Months Ended | |||||||
Mar. 31, 2023 | Dec. 31, 2021 | Dec. 02, 2021 | Dec. 01, 2021 | Nov. 30, 2021 | Mar. 31, 2023 | Jan. 26, 2022 | Dec. 24, 2021 | |
Ownership interest, percent | 42.20% | 42.20% | ||||||
Joint Venture | ||||||||
Ownership interest, percent | 48.80% | 50.90% | ||||||
Facility in Liangjiang New Area of Chongqing (the 'Joint Venture') | Joint Venture | Third Party Investor | ||||||||
Ownership interest sold, percent | 7.82% | 1.10% | ||||||
Facility in Liangjiang New Area of Chongqing (the 'Joint Venture') | Joint Venture | Employee Incentive Plan | Employee Incentive Plan | ||||||||
Ownership interest sold, percent | 3.99% | |||||||
Third Party Investor | Joint Venture | Third Party Investor | ||||||||
Ownership interest sold, percent | 2.10% | 1.10% | ||||||
Third Party Investor | Joint Venture | Employee Incentive Plan | Employee Incentive Plan | ||||||||
Ownership interest sold, percent | 3.99% | |||||||
Parent Company | Facility in Liangjiang New Area of Chongqing (the 'Joint Venture') | ||||||||
Ownership interest, percent | 50.90% | |||||||
Chongqing Funds | Facility in Liangjiang New Area of Chongqing (the 'Joint Venture') | ||||||||
Ownership interest, percent | 45.80% | 49.10% |
The Company and Significant A_4
The Company and Significant Accounting Policies - Revenue (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | |||
Mar. 31, 2023 | Mar. 31, 2022 | Mar. 31, 2023 | Mar. 31, 2022 | Feb. 28, 2023 | |
Revenues from External Customers and Long-Lived Assets | |||||
Remaining performance obligation | $ 45,000 | ||||
Upfront fees | $ 18,000 | $ 18,000 | |||
Revenue | 132,560 | $ 203,239 | 529,796 | $ 583,593 | |
License and development services | |||||
Revenues from External Customers and Long-Lived Assets | |||||
Revenue | $ 3,630 | $ 0 | $ 3,630 | $ 0 |
The Company and Significant A_5
The Company and Significant Accounting Policies - Restricted Cash (Details) - USD ($) $ in Millions | Mar. 31, 2023 | Jun. 30, 2022 |
Accounting Policies [Abstract] | ||
Restricted cash | $ 0.2 | $ 0.3 |
The Company and Significant A_6
The Company and Significant Accounting Policies - Government Grants (Details) - USD ($) $ in Millions | 3 Months Ended | 9 Months Ended | ||
Mar. 31, 2023 | Mar. 31, 2022 | Mar. 31, 2023 | Mar. 31, 2022 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | ||||
Government Grants, Reduction Recorded To Property, Plant And Equipment | $ 0 | $ 0.6 | $ 1.2 | |
Government Grants, Reduction Recorded To Operating Expenses | $ 0 | 0 | $ 0.1 | 0.2 |
Government Grants, Reduction Recorded To Interest Expense | $ 0 | $ 0.9 |
Equity Method Investment in E_2
Equity Method Investment in Equity Investee - Narrative (Details) $ in Thousands, ¥ in Millions | 3 Months Ended | 9 Months Ended | ||||||||||
Mar. 31, 2023 | Jan. 26, 2022 USD ($) | Jan. 26, 2022 CNY (¥) | Dec. 31, 2021 | Dec. 02, 2021 director | Dec. 01, 2021 | Nov. 30, 2021 director | Mar. 31, 2023 USD ($) | Mar. 31, 2022 USD ($) | Mar. 31, 2023 USD ($) | Mar. 31, 2022 USD ($) | Dec. 24, 2021 | |
Schedule of Equity Method Investments [Line Items] | ||||||||||||
Ownership interest, percent | 42.20% | 42.20% | ||||||||||
Number of appointments to board of directors | director | 3 | 4 | ||||||||||
Number of directors on Board | director | 7 | |||||||||||
Proceeds from sale of equity interest in the JV Company | $ | $ 0 | $ 26,347 | ||||||||||
Equity method investment income (loss) from equity investee | $ | $ (1,480) | $ (1,136) | $ 1,533 | $ (1,136) | ||||||||
Facility in Liangjiang New Area of Chongqing (the 'Joint Venture') | Chongqing Funds | ||||||||||||
Schedule of Equity Method Investments [Line Items] | ||||||||||||
Ownership interest, percent | 45.80% | 49.10% | ||||||||||
Joint Venture | ||||||||||||
Schedule of Equity Method Investments [Line Items] | ||||||||||||
Ownership interest, percent | 48.80% | 50.90% | ||||||||||
Third Party Investor | Joint Venture | ||||||||||||
Schedule of Equity Method Investments [Line Items] | ||||||||||||
Proceeds from sale of equity interest in the JV Company | $ 80,000 | ¥ 509 | ||||||||||
Third Party Investor | Joint Venture | Facility in Liangjiang New Area of Chongqing (the 'Joint Venture') | ||||||||||||
Schedule of Equity Method Investments [Line Items] | ||||||||||||
Ownership interest sold, percent | 7.82% | 7.82% | 1.10% | |||||||||
Employee Incentive Plan | Joint Venture | Facility in Liangjiang New Area of Chongqing (the 'Joint Venture') | Employee Incentive Plan | ||||||||||||
Schedule of Equity Method Investments [Line Items] | ||||||||||||
Ownership interest sold, percent | 3.99% |
Related Party Transactions (Det
Related Party Transactions (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||||||
Mar. 31, 2023 | Dec. 02, 2021 | Nov. 30, 2021 | Mar. 31, 2023 | Mar. 31, 2022 | Mar. 31, 2023 | Mar. 31, 2022 | Jun. 30, 2022 | |
Related Party Transaction [Line Items] | ||||||||
Ownership interest, percent | 42.20% | 42.20% | ||||||
Payable related to equity investee, net | $ 18,393 | $ 18,393 | $ 18,393 | $ 28,989 | ||||
Joint Venture | ||||||||
Related Party Transaction [Line Items] | ||||||||
Ownership interest, percent | 48.80% | 50.90% | ||||||
Purchases from related party | 20,200 | $ 45,800 | 106,100 | $ 61,400 | ||||
Sales from related party | $ 4,000 | $ 14,200 | $ 34,400 | $ 18,400 |
Net Income (Loss) Per Common _3
Net Income (Loss) Per Common Share Attributable to Alpha and Omega Semiconductor Limited - Basic and Diluted Income Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Mar. 31, 2023 | Mar. 31, 2022 | Mar. 31, 2023 | Mar. 31, 2022 | |
Numerator: | ||||
Net income (loss) attributable to Alpha and Omega Semiconductor Limited | $ (18,907) | $ 31,650 | $ 13,468 | $ 438,072 |
Basic: | ||||
Weighted average number of common shares used to compute basic net income (loss) per share | 27,710 | 26,829 | 27,537 | 26,596 |
Effect of potentially dilutive securities: | ||||
Stock options, RSUs and ESPP shares | 0 | 1,594 | 2,039 | 1,520 |
Weighted average number of common shares used to compute diluted net income (loss) per share | 27,710 | 28,423 | 29,576 | 28,116 |
Net income (loss) per share attributable to Alpha and Omega Semiconductor Limited: | ||||
Basic (in dollars per share) | $ (0.68) | $ 1.18 | $ 0.49 | $ 16.47 |
Diluted (in dollars per share) | $ (0.68) | $ 1.11 | $ 0.46 | $ 15.58 |
Net Income (Loss) Per Common _4
Net Income (Loss) Per Common Share Attributable to Alpha and Omega Semiconductor Limited - Potential Dilutive Shares (Details) - shares shares in Thousands | 3 Months Ended | 9 Months Ended | ||
Mar. 31, 2023 | Mar. 31, 2022 | Mar. 31, 2023 | Mar. 31, 2022 | |
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||
Potential dilutive securities (in shares) | 3,919 | 21 | 560 | 198 |
Employee stock options and RSUs | ||||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||
Potential dilutive securities (in shares) | 3,152 | 2 | 281 | 171 |
ESPP | ||||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||
Potential dilutive securities (in shares) | 767 | 19 | 279 | 27 |
Concentration of Credit Risk _3
Concentration of Credit Risk and Significant Customers - (Details) | 3 Months Ended | 9 Months Ended | ||||
Mar. 31, 2023 | Jun. 30, 2022 | Mar. 31, 2023 | Mar. 31, 2022 | Mar. 31, 2023 | Mar. 31, 2022 | |
Customer Concentration Risk | Customer A | Revenue | ||||||
Concentration Risk | ||||||
Customers greater than 10% of total | 21% | 24.20% | 21.70% | 24.80% | ||
Customer Concentration Risk | Customer A | Accounts Receivable | ||||||
Concentration Risk | ||||||
Customers greater than 10% of total | 24.60% | |||||
Customer Concentration Risk | Customer B | Revenue | ||||||
Concentration Risk | ||||||
Customers greater than 10% of total | 28.70% | 38.80% | 35.50% | 38.70% | ||
Customer Concentration Risk | Customer B | Accounts Receivable | ||||||
Concentration Risk | ||||||
Customers greater than 10% of total | 36.40% | |||||
Customer Concentration Risk | Customer C | Revenue | ||||||
Concentration Risk | ||||||
Customers greater than 10% of total | 17.90% | 14.10% | ||||
Customer Concentration Risk | Customer C | Accounts Receivable | ||||||
Concentration Risk | ||||||
Customers greater than 10% of total | 46% | 12% | ||||
Customer Concentration Risk | Customer D | Accounts Receivable | ||||||
Concentration Risk | ||||||
Customers greater than 10% of total | 21.90% | |||||
Minimum | ||||||
Concentration Risk | ||||||
Terms of credit sales, (in days) | 30 days | |||||
Maximum | ||||||
Concentration Risk | ||||||
Terms of credit sales, (in days) | 60 days |
Balance Sheet Components - Acco
Balance Sheet Components - Accounts receivable (Details) - USD ($) $ in Thousands | Mar. 31, 2023 | Jun. 30, 2022 |
Balance Sheet Related Disclosures [Abstract] | ||
Accounts receivable | $ 54,269 | $ 84,442 |
Less: Allowance for price adjustments | (34,805) | (18,731) |
Less: Allowance for doubtful accounts | (30) | (30) |
Accounts receivable, net | $ 19,434 | $ 65,681 |
Balance Sheet Components - Inve
Balance Sheet Components - Inventories (Details) - USD ($) $ in Thousands | Mar. 31, 2023 | Jun. 30, 2022 |
Balance Sheet Related Disclosures [Abstract] | ||
Raw materials | $ 86,490 | $ 67,960 |
Work-in-process | 69,905 | 80,720 |
Finished goods | 23,388 | 9,360 |
Inventory, net | $ 179,783 | $ 158,040 |
Balance Sheet Components - Othe
Balance Sheet Components - Other current assets (Details) - USD ($) $ in Thousands | Mar. 31, 2023 | Jun. 30, 2022 |
Balance Sheet Related Disclosures [Abstract] | ||
Value-added tax receivable | $ 179 | $ 737 |
Other prepaid expenses | 3,950 | 3,954 |
Prepaid insurance | 751 | 2,590 |
Prepaid maintenance | 1,092 | 826 |
Prepayment to supplier | 71 | 257 |
Prepaid income tax | 2,176 | 2,086 |
Interest Receivable, Current | 172 | 25 |
Other receivables | 1,578 | 745 |
Other Assets, Current | $ 9,969 | $ 11,220 |
Balance Sheet Components - Prop
Balance Sheet Components - Property, plant, and equipment (Details) - USD ($) $ in Thousands | Mar. 31, 2023 | Jun. 30, 2022 |
Property, Plant and Equipment | ||
Property, plant, and equipment excluding equipment and construction In progress, gross | $ 473,286 | $ 422,026 |
Less: accumulated depreciation | (261,814) | (233,340) |
Property, plant and equipment excluding equipment and construction in progress, net | 211,472 | 188,686 |
Equipment and construction in progress | 146,685 | 129,980 |
Property, plant and equipment, net | 358,157 | 318,666 |
Land | ||
Property, Plant and Equipment | ||
Property, plant, and equipment excluding equipment and construction In progress, gross | 4,877 | 4,877 |
Building | ||
Property, Plant and Equipment | ||
Property, plant, and equipment excluding equipment and construction In progress, gross | 26,243 | 16,691 |
Manufacturing machinery and equipment | ||
Property, Plant and Equipment | ||
Property, plant, and equipment excluding equipment and construction In progress, gross | 320,087 | 287,574 |
Equipment and tooling | ||
Property, Plant and Equipment | ||
Property, plant, and equipment excluding equipment and construction In progress, gross | 31,428 | 28,052 |
Computer equipment and software | ||
Property, Plant and Equipment | ||
Property, plant, and equipment excluding equipment and construction In progress, gross | 49,425 | 46,758 |
Office furniture and equipment | ||
Property, Plant and Equipment | ||
Property, plant, and equipment excluding equipment and construction In progress, gross | 3,175 | 2,820 |
Leasehold improvements | ||
Property, Plant and Equipment | ||
Property, plant, and equipment excluding equipment and construction In progress, gross | $ 38,051 | $ 35,254 |
Balance Sheet Components - Inta
Balance Sheet Components - Intangible assets (Details) - USD ($) $ in Thousands | Mar. 31, 2023 | Jun. 30, 2022 |
Schedule of Finite-lived Intangible Assets and Goodwill | ||
Finite-Lived Intangible Assets, Gross | $ 19,455 | $ 19,455 |
Less: accumulated amortization | (12,147) | (9,674) |
Total intangible assets | 7,308 | 9,781 |
Goodwill | 269 | 269 |
Intangible assets, net | 7,577 | 10,050 |
Patents and technology rights | ||
Schedule of Finite-lived Intangible Assets and Goodwill | ||
Finite-Lived Intangible Assets, Gross | 18,037 | 18,037 |
Trade name | ||
Schedule of Finite-lived Intangible Assets and Goodwill | ||
Finite-Lived Intangible Assets, Gross | 268 | 268 |
Customer relationships | ||
Schedule of Finite-lived Intangible Assets and Goodwill | ||
Finite-Lived Intangible Assets, Gross | $ 1,150 | $ 1,150 |
Balance Sheet Components - Futu
Balance Sheet Components - Future Amortization of Intangible Assets (Details) - USD ($) $ in Thousands | Mar. 31, 2023 | Jun. 30, 2022 |
Balance Sheet Related Disclosures [Abstract] | ||
2023 (Remaining) | $ 812 | |
2024 | 3,249 | |
2025 | 3,247 | |
Total intangible assets | $ 7,308 | $ 9,781 |
Balance Sheet Components - Ot_2
Balance Sheet Components - Other long term assets (Details) - USD ($) $ in Thousands | Mar. 31, 2023 | Jun. 30, 2022 |
Balance Sheet Related Disclosures [Abstract] | ||
Prepayments for property and equipment | $ 1,013 | $ 6,890 |
Investment in a privately held company | 100 | 100 |
Customs deposit | 2,118 | 1,708 |
Deposit with supplier | 13,040 | 6,396 |
Other long-term deposits | 33 | 18 |
Office leases deposits | 1,243 | 1,012 |
Other | 3,111 | 1,553 |
Other long-term assets | $ 20,658 | $ 17,677 |
Balance Sheet Components - Accr
Balance Sheet Components - Accrued liabilities (Details) - USD ($) $ in Thousands | Mar. 31, 2023 | Jun. 30, 2022 | Mar. 31, 2022 | Jun. 30, 2021 |
Accrued Liabilities | ||||
Accrued compensation and benefits | $ 18,750 | $ 34,681 | ||
Warranty accrual | 3,815 | 2,650 | $ 2,483 | $ 2,795 |
Stock rotation accrual | 4,081 | 4,798 | $ 4,207 | $ 3,917 |
Accrued professional fees | 2,407 | 2,659 | ||
Accrued inventory | 1,322 | 2,491 | ||
Accrued facilities related expenses | 2,285 | 2,421 | ||
Accrued property, plant and equipment | 6,531 | 20,485 | ||
Other accrued expenses | 4,160 | 5,159 | ||
Customer deposits | 43,314 | 40,578 | ||
ESPP payable | 3,364 | 971 | ||
Accrued liabilities | 90,029 | 116,893 | ||
Customer A | ||||
Accrued Liabilities | ||||
Customer deposits | 12,500 | 12,500 | ||
Customer B | ||||
Accrued Liabilities | ||||
Customer deposits | 10,200 | 16,200 | ||
Other Customer | ||||
Accrued Liabilities | ||||
Customer deposits | $ 20,600 | $ 11,900 |
Balance Sheet Components - Prod
Balance Sheet Components - Product Warranty Accrual (Details) - USD ($) $ in Thousands | 9 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Movement in Standard and Extended Product Warranty Accrual, Increase (Decrease) | ||
Beginning balance | $ 2,650 | $ 2,795 |
Additions | 2,915 | 949 |
Utilization | (1,750) | (1,261) |
Ending balance | $ 3,815 | $ 2,483 |
Balance Sheet Components - Stoc
Balance Sheet Components - Stock Rotation Accrual (Details) - USD ($) $ in Thousands | 9 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Stock Rotation Accrual Increase (Decrease) | ||
Beginning balance | $ 4,798 | $ 3,917 |
Additions | 9,187 | 3,030 |
Utilization | (9,904) | (2,740) |
Ending balance | $ 4,081 | $ 4,207 |
Balance Sheet Components - Ot_3
Balance Sheet Components - Other Long-Term Liabilities (Details) - USD ($) $ in Thousands | Mar. 31, 2023 | Jun. 30, 2022 |
Concentration Risk | ||
Customer deposits | $ 51,926 | $ 70,301 |
Computer software liabilities | 5,773 | 8,302 |
Other long-term liabilities | 57,699 | 78,603 |
Customer A | ||
Concentration Risk | ||
Customer deposits | 22,000 | 34,500 |
Customer B | ||
Concentration Risk | ||
Customer deposits | 13,700 | 21,900 |
Other Customers | ||
Concentration Risk | ||
Customer deposits | $ 16,200 | $ 13,900 |
Bank Borrowing - Narrative (Det
Bank Borrowing - Narrative (Details) € in Millions | 1 Months Ended | 9 Months Ended | |||||||||||
Feb. 16, 2022 USD ($) | Aug. 18, 2021 USD ($) | Aug. 09, 2019 USD ($) | May 01, 2018 USD ($) | Sep. 30, 2022 USD ($) | Mar. 31, 2023 USD ($) | Mar. 31, 2023 EUR (€) | Jan. 31, 2023 USD ($) | Jan. 31, 2023 CNY (¥) | Jun. 30, 2022 USD ($) | Mar. 31, 2022 USD ($) | Aug. 11, 2021 USD ($) | Apr. 30, 2021 EUR (€) | |
Debt Instrument [Line Items] | |||||||||||||
Lease completion buyout option, amount | $ 1 | ||||||||||||
Long-term debt | $ 41,237,000 | $ 42,486,000 | |||||||||||
Jireh Semiconductor Incorporated | Sales-Lease Back Transaction with Jireh Semiconductor Incorporated | |||||||||||||
Debt Instrument [Line Items] | |||||||||||||
Debt financing term (in years) | 5 years | ||||||||||||
Implied interest rate | 7.51% | 4.75% | |||||||||||
Historical cost | € | € 12 | ||||||||||||
Down payment amount | € | € 6 | ||||||||||||
Down payment percent | 50% | 50% | |||||||||||
Delivery payment, percent | 40% | ||||||||||||
Delivery payment, amount | $ 4,800,000 | ||||||||||||
Purchase price financing, percent | 10% | ||||||||||||
Payments for purchase of optional hardware | $ 200,000 | ||||||||||||
Outstanding balance | $ 12,500,000 | ||||||||||||
Jireh Semiconductor Incorporated | Sales-Lease Back Transaction with Jireh Semiconductor Incorporated | Manufacturing machinery and equipment | |||||||||||||
Debt Instrument [Line Items] | |||||||||||||
Collateral amount | 13,100,000 | ||||||||||||
Secured Debt | Accounts Receivable Factoring Agreement August 9 2019 | |||||||||||||
Debt Instrument [Line Items] | |||||||||||||
Accounts Receivable Factoring Agreement, Reduction Of Maximum Borrowing Capacity | $ 8,000,000 | ||||||||||||
Secured Debt | Jireh | |||||||||||||
Debt Instrument [Line Items] | |||||||||||||
Line of credit facility, maximum borrowing capacity | $ 45,000,000 | ||||||||||||
Debt instrument, term | 5 years 6 months | ||||||||||||
Amount outstanding | 40,500,000 | ||||||||||||
Proceeds from lines of credit | $ 45,000,000 | ||||||||||||
Bank Of Communications Limited | Line of Credit | Line Of Credit Maturing December 1 2023 | |||||||||||||
Debt Instrument [Line Items] | |||||||||||||
Line of credit facility, maximum borrowing capacity | $ 20,600,000 | ¥ 140,000,000 | |||||||||||
Long-Term Line of Credit | 0 | ||||||||||||
Hongkong And Shanghai Banking Corporation Limited | Secured Debt | Accounts Receivable Factoring Agreement August 9 2019 | |||||||||||||
Debt Instrument [Line Items] | |||||||||||||
Basis spread on variable rate | 1.75% | ||||||||||||
Accounts receivable factoring agreement, maximum borrowing capacity, percent of net accounts receivable | 70% | ||||||||||||
Accounts receivable factoring agreement, maximum borrowing capacity | $ 30,000,000 | ||||||||||||
Accounts receivable factoring agreement, remaining borrowing capacity | 8,000,000 | ||||||||||||
Accounts receivable factoring agreement, borrowed amount outstanding | 0 | ||||||||||||
The Bank | Secured Debt | |||||||||||||
Debt Instrument [Line Items] | |||||||||||||
Line of credit facility, maximum borrowing capacity | $ 17,800,000 | ||||||||||||
Debt instrument, term | 5 years | ||||||||||||
Amount outstanding | $ 13,500,000 | ||||||||||||
Stated percentage | 5.04% |
Bank Borrowing - Schedule of De
Bank Borrowing - Schedule of Debt Maturities (Details) - USD ($) $ in Thousands | Mar. 31, 2023 | Jun. 30, 2022 |
Debt Disclosure [Abstract] | ||
2023 (Remaining) | $ 16,339 | |
2024 | 11,472 | |
2025 | 11,664 | |
2026 | 11,871 | |
2027 | 14,344 | |
Thereafter | 536 | |
Total principal, less debt issuance costs | 66,226 | |
Less: debt issuance costs | (112) | |
Debt, Long-Term And Short-Term, Combined Amount, Net | 66,114 | |
Short-term Debt [Abstract] | ||
Principal amount | 24,925 | |
Less: debt issuance costs | (48) | |
Total debt, less debt issuance costs | 24,877 | |
Long-term Debt, Unclassified [Abstract] | ||
Principal amount | 41,301 | |
Less: debt issuance costs | (64) | |
Total debt, less debt issuance costs | $ 41,237 | $ 42,486 |
Leases - Narrative (Details)
Leases - Narrative (Details) $ in Thousands, ¥ in Millions | Mar. 31, 2023 USD ($) | Jun. 30, 2022 USD ($) | May 09, 2018 CNY (¥) |
Debt Instrument [Line Items] | |||
Operating lease liability | $ 23,789 | ||
ROU assets associated with operating leases | 22,962 | $ 23,674 | |
Property, plant and equipment, gross | $ 5,133 | $ 4,831 | |
Lease Financing | YinHai Leasing Company and China Import/Export Bank | YinHai Leasing Company and China Import/Export Bank | |||
Debt Instrument [Line Items] | |||
Line of credit facility, maximum borrowing capacity | ¥ | ¥ 400 |
Leases - Schedule of Operating
Leases - Schedule of Operating and Finance Lease Expenses (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Mar. 31, 2023 | Mar. 31, 2022 | Mar. 31, 2023 | Mar. 31, 2022 | |
Operating leases: | ||||
Fixed rent expense | $ 1,385 | $ 1,479 | $ 4,298 | $ 4,955 |
Variable rent expense | 279 | 126 | 757 | 741 |
Finance lease: | ||||
Amortization of equipment | 128 | 15 | 393 | 787 |
Interest | 83 | 11 | 227 | 692 |
Short-term leases | ||||
Short-term lease expenses | 133 | 38 | 300 | 144 |
Total lease expenses | $ 2,008 | $ 1,669 | $ 5,975 | $ 7,319 |
Leases - Supplemental Balance S
Leases - Supplemental Balance Sheet Information (Details) - USD ($) $ in Thousands | Mar. 31, 2023 | Jun. 30, 2022 |
Operating Leases: | ||
ROU assets associated with operating leases | $ 22,962 | $ 23,674 |
Finance Lease: | ||
Property, plant and equipment, gross | 5,133 | 4,831 |
Accumulated depreciation | (529) | (136) |
Property, plant and equipment, net | $ 4,604 | $ 4,695 |
Weighted average remaining lease term (in years) | ||
Operating leases | 6 years 7 months 24 days | 7 years 5 months 1 day |
Finance lease | 4 years 6 months | 5 years |
Weighted average discount rate | ||
Operating leases | 4.39% | 4.27% |
Finance lease | 7.51% | 4.76% |
Leases - Supplemental Cash Flow
Leases - Supplemental Cash Flow Information (Details) - USD ($) $ in Thousands | 9 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Cash paid from amounts included in the measurement of lease liabilities: | ||
Operating cash flows from operating leases | $ 4,418 | $ 4,965 |
Operating cash flows from finance lease | 227 | 421 |
Financing cash flows from finance lease | 603 | 4,176 |
Operating lease right-of-use assets obtained in exchange for lease obligations | $ 2,859 | $ 5,901 |
Leases - Future Minimum Lease P
Leases - Future Minimum Lease Payments (Topic 842) (Details) $ in Thousands | Mar. 31, 2023 USD ($) |
Operating Leases | |
The remainder of fiscal 2023 | $ 1,481 |
2024 | 5,006 |
2025 | 4,133 |
2026 | 3,441 |
2027 | 3,264 |
Thereafter | 10,301 |
Total minimum lease payments | 27,626 |
Less amount representing interest | (3,837) |
Total Operating Lease Liability | 23,789 |
Finance Leases | |
The remainder of fiscal 2023 | 286 |
2024 | 1,144 |
2025 | 1,144 |
2026 | 1,144 |
2027 | 1,145 |
Thereafter | 191 |
Total minimum lease payments | 5,054 |
Less amount representing interest | (764) |
Total Finance Lease Liability | $ 4,290 |
Shareholders' Equity and Shar_3
Shareholders' Equity and Share-based Compensation - Shares Repurchase (Details) - USD ($) $ / shares in Units, $ in Thousands | 3 Months Ended | 9 Months Ended | 149 Months Ended | |||
Mar. 31, 2023 | Mar. 31, 2022 | Mar. 31, 2023 | Mar. 31, 2022 | Mar. 31, 2023 | Sep. 30, 2017 | |
Class of Stock [Line Items] | ||||||
Treasury Stock, Shares, Retired | 0 | |||||
Share repurchase program, authorized amount (USD in Millions) | $ 30,000 | |||||
Repurchase of common shares under shares repurchase program | 106,863 | 6,891,511 | ||||
Treasury stock acquired, average price per share (in dollars per share) | $ 24.9 | $ 10.16 | ||||
Treasury Stock, Value, Acquired, Cost Method | $ (2,700) | $ (70,000) | ||||
Shares repurchase program, remaining balance | $ 10,800 | $ 10,800 | $ 10,800 | |||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | 0 | 0 | 0 | 0 | ||
Share-based compensation expense | $ 10,432 | $ 8,273 | $ 34,119 | $ 21,454 | ||
Treasury Stock Reissued | ||||||
Class of Stock [Line Items] | ||||||
Treasury stock acquired, average price per share (in dollars per share) | $ 9.98 | |||||
Shares reissued (in shares) | 174,724 | |||||
Shares reissued, average price (in dollars per share) | $ 4.79 | |||||
2018 Market-based Restricted Stock Units (MSU) | ||||||
Class of Stock [Line Items] | ||||||
Share-based compensation expense | $ 300 | $ 400 | $ 3,600 | $ 1,200 |
Shareholders' Equity and Shar_4
Shareholders' Equity and Share-based Compensation - Time-based Restricted Stock Activity (Details) | 9 Months Ended | |
Jun. 30, 2022 USD ($) $ / shares shares | Mar. 31, 2023 USD ($) $ / shares shares | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward] | ||
Weighted average remaining recognition period (in years) | 2 years 9 months 18 days | |
Restricted Stock | ||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] | ||
Nonvested at beginning of period (in shares) | shares | 1,169,609 | |
Granted (in shares) | shares | 625,080 | |
Vested (in shares) | shares | (418,269) | |
Forfeited (in shares) | shares | (35,025) | |
Nonvested at end of period (in shares) | shares | 1,169,609 | 1,341,395 |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward] | ||
Nonvested at beginning of period (in dollars per share) | $ / shares | $ 34.03 | |
Granted (in dollars per share) | $ / shares | 28.14 | |
Vested (in dollars per share) | $ / shares | 28.90 | |
Forfeited (in dollars per share) | $ / shares | 31.34 | |
Nonvested at end of period (in dollars per share | $ / shares | $ 34.03 | $ 32.96 |
Weighted average remaining recognition period (in years) | 1 year 8 months 23 days | 1 year 10 months 20 days |
Aggregate Intrinsic Value | $ | $ 38,994,764 | $ 36,150,595 |
Shareholders' Equity and Shar_5
Shareholders' Equity and Share-based Compensation - Market-based Restricted Stock Units Narrative (Details) - USD ($) $ / shares in Units, $ in Thousands | 1 Months Ended | 3 Months Ended | 9 Months Ended | |||
Dec. 31, 2021 | Mar. 31, 2023 | Mar. 31, 2022 | Sep. 30, 2018 | Mar. 31, 2023 | Mar. 31, 2022 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||
Share-based compensation expense | $ 10,432 | $ 8,273 | $ 34,119 | $ 21,454 | ||
2021 Market-based Restricted Stock Units (MSU) | ||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||
Risk-free interest rate | 1% | |||||
Expected term | 3 years 1 month 6 days | |||||
Dividend yield | 0% | |||||
Share-based compensation expense | 2,100 | 2,000 | 6,200 | 2,500 | ||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] | ||||||
Granted (in shares) | 1,000,000 | |||||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward] | ||||||
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | 62.80% | |||||
2021 Market-based Restricted Stock Units (MSU) | Minimum | ||||||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward] | ||||||
Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period | 4 years 1 month 6 days | |||||
2021 Market-based Restricted Stock Units (MSU) | Maximum | ||||||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward] | ||||||
Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period | 7 years 1 month 6 days | |||||
2018 Market-based Restricted Stock Units (MSU) | ||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||
Share-based compensation expense | 300 | 400 | 3,600 | 1,200 | ||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] | ||||||
Granted (in shares) | 1,300,000 | |||||
Performance Based Restricted Stock Units (PRSUs) Member | ||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||
Share-based compensation expense | $ 1,400 | $ 1,000 | $ 4,100 | $ 3,000 | ||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] | ||||||
Nonvested at beginning of period (in shares) | 389,375 | |||||
Granted (in shares) | 264,214 | |||||
Vested (in shares) | (116,132) | |||||
Forfeited (in shares) | (10,743) | |||||
Nonvested at end of period (in shares) | 526,714 | 526,714 | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward] | ||||||
Nonvested at beginning of period (in dollars per share) | $ 36.56 | |||||
Granted (in dollars per share) | 25.70 | |||||
Vested (in dollars per share) | 30.54 | |||||
Forfeited (in dollars per share) | 48.65 | |||||
Nonvested at end of period (in dollars per share | $ 32.19 | $ 32.19 |
Shareholders' Equity and Shar_6
Shareholders' Equity and Share-based Compensation - Performance-based Restricted Stock Units (Details) - USD ($) | 3 Months Ended | 9 Months Ended | ||||
Mar. 31, 2023 | Jun. 30, 2022 | Mar. 31, 2023 | Mar. 31, 2022 | Mar. 31, 2023 | Mar. 31, 2022 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||
Share-based compensation expense | $ 10,432,000 | $ 8,273,000 | $ 34,119,000 | $ 21,454,000 | ||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward] | ||||||
Weighted average remaining recognition period (in years) | 2 years 9 months 18 days | |||||
Performance Based Restricted Stock Units (PRSUs) Member | ||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||
Share-based compensation expense | $ 1,400,000 | $ 1,000,000 | $ 4,100,000 | $ 3,000,000 | ||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] | ||||||
Nonvested at beginning of period (in shares) | 389,375 | |||||
Granted (in shares) | 264,214 | |||||
Vested (in shares) | (116,132) | |||||
Forfeited (in shares) | (10,743) | |||||
Nonvested at end of period (in shares) | 526,714 | 389,375 | 526,714 | 526,714 | ||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward] | ||||||
Nonvested at beginning of period (in dollars per share) | $ 36.56 | |||||
Granted (in dollars per share) | 25.70 | |||||
Vested (in dollars per share) | 30.54 | |||||
Forfeited (in dollars per share) | 48.65 | |||||
Nonvested at end of period (in dollars per share | $ 32.19 | $ 36.56 | $ 32.19 | $ 32.19 | ||
Weighted average remaining recognition period (in years) | 2 years 10 days | 1 year 10 months 6 days | ||||
Aggregate Intrinsic Value | $ 14,194,942 | $ 12,981,763 | $ 14,194,942 | $ 14,194,942 |
Shareholders' Equity and Shar_7
Shareholders' Equity and Share-based Compensation - Stock Options Outstanding and Exercisable (Details) - USD ($) | 9 Months Ended | |
Jun. 30, 2022 | Mar. 31, 2023 | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] | ||
Outstanding at beginning of period (in shares) | 389,875 | |
Exercised (in shares) | (65,500) | |
Outstanding at end of period (In shares) | 389,875 | 324,375 |
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value | $ 1,442,646 | |
Options vested and expected to vest (in shares) | 324,375 | |
Exercisable at end of period (in shares) | 324,375 | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward] | ||
Outstanding at beginning of period (in dollars per share) | $ 7.70 | |
Exercised (in dollars per share) | 8.42 | |
Outstanding at end of period (in dollars per share) | $ 7.70 | 7.55 |
Options vested and expected to vest (in dollars per share) | 7.55 | |
Exercisable at end of period (in dollars per share) | $ 7.55 | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] | ||
Options outstanding, Weighted-Average Remaining Contractual Life (in years) | 1 year 6 months 10 days | 11 months 15 days |
Options vested and expected to vest, Weighted Average Remaining Contractual Life (in years) | 11 months 15 days | |
Exercisable at end of period, Weighted Average Remaining Contractual Life (in years) | 11 months 15 days | |
Options outstanding, Aggregate Intrinsic Value | $ 9,997,364 | $ 6,292,088 |
Options vested and expected to vest, Aggregate Intrinsic Value | 6,292,088 | |
Exercisable at end of period, Aggregate Intrinsic Value | $ 6,292,088 |
Shareholders' Equity and Shar_8
Shareholders' Equity and Share-based Compensation - Employee Share Purchase Plan (Details) - shares | 3 Months Ended | 9 Months Ended | 149 Months Ended |
Mar. 31, 2023 | Mar. 31, 2023 | Mar. 31, 2023 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Repurchase of common shares under shares repurchase program | 106,863 | 6,891,511 | |
ESPP | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Volatility rate | 70.50% | ||
Risk-free interest rate | 4.50% | ||
Expected term | 1 year 3 months 18 days | ||
Dividend yield | 0% |
Shareholders' Equity and Shar_9
Shareholders' Equity and Share-based Compensation - Share-based Compensation (Details) - USD ($) | 3 Months Ended | 9 Months Ended | 149 Months Ended | |||||
Sep. 08, 2022 | Jun. 30, 2022 | Mar. 31, 2023 | Mar. 31, 2022 | Sep. 30, 2018 | Mar. 31, 2023 | Mar. 31, 2022 | Mar. 31, 2023 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||
Share-based compensation expense | $ 10,432,000 | $ 8,273,000 | $ 34,119,000 | $ 21,454,000 | ||||
Repurchase of common shares under shares repurchase program | 106,863 | 6,891,511 | ||||||
Options outstanding, Weighted-Average Remaining Contractual Life (in years) | 1 year 6 months 10 days | 11 months 15 days | ||||||
Options vested and expected to vest (in shares) | 324,375 | 324,375 | 324,375 | |||||
Options vested and expected to vest (in dollars per share) | $ 7.55 | $ 7.55 | $ 7.55 | |||||
Options vested and expected to vest, Weighted Average Remaining Contractual Life (in years) | 11 months 15 days | |||||||
Options vested and expected to vest, Aggregate Intrinsic Value | $ 6,292,088 | $ 6,292,088 | $ 6,292,088 | |||||
Exercisable at end of period (in shares) | 324,375 | 324,375 | 324,375 | |||||
Exercisable at end of period (in dollars per share) | $ 7.55 | $ 7.55 | $ 7.55 | |||||
Exercisable at end of period, Weighted Average Remaining Contractual Life (in years) | 11 months 15 days | |||||||
Exercisable at end of period, Aggregate Intrinsic Value | $ 6,292,088 | $ 6,292,088 | $ 6,292,088 | |||||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] | ||||||||
Outstanding at beginning of period (in shares) | 389,875 | |||||||
Outstanding at end of period (In shares) | 389,875 | 324,375 | 324,375 | 324,375 | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward] | ||||||||
Outstanding at beginning of period (in dollars per share) | $ 7.70 | |||||||
Outstanding at end of period (in dollars per share) | $ 7.70 | $ 7.55 | $ 7.55 | $ 7.55 | ||||
Options outstanding, Aggregate Intrinsic Value | $ 9,997,364 | $ 6,292,088 | $ 6,292,088 | $ 6,292,088 | ||||
Director | ||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||
Share-based compensation expense | 0 | 3,100,000 | ||||||
Plan modification, incremental cost | $ 3,900,000 | |||||||
2018 Market-based Restricted Stock Units (MSU) | ||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||
Share-based compensation expense | 300,000 | 400,000 | 3,600,000 | 1,200,000 | ||||
Granted (in shares) | 1,300,000 | |||||||
Performance Based Restricted Stock Units (PRSUs) Member | ||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||
Share-based compensation expense | $ 1,400,000 | $ 1,000,000 | $ 4,100,000 | $ 3,000,000 | ||||
Granted (in shares) | 264,214 |
Shareholders' Equity and Sha_10
Shareholders' Equity and Share-based Compensation - Share-based Compensation Expenses (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | |||
Sep. 08, 2022 | Mar. 31, 2023 | Mar. 31, 2022 | Mar. 31, 2023 | Mar. 31, 2022 | |
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | |||||
Share-based compensation expense | $ 10,432 | $ 8,273 | $ 34,119 | $ 21,454 | |
Unrecognized compensation expense | 77,500 | $ 77,500 | |||
Recognition period of share-based compensation expense (in years) | 2 years 9 months 18 days | ||||
Director | |||||
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | |||||
Plan modification, incremental cost | $ 3,900 | ||||
Share-based compensation expense | 0 | $ 3,100 | |||
Cost of goods sold | |||||
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | |||||
Share-based compensation expense | 1,723 | 1,282 | 5,259 | 3,560 | |
Research and development | |||||
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | |||||
Share-based compensation expense | 2,987 | 1,814 | 8,808 | 4,769 | |
Selling, general and administrative | |||||
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | |||||
Share-based compensation expense | $ 5,722 | $ 5,177 | $ 20,052 | $ 13,125 |
Income Taxes - Narrative (Detai
Income Taxes - Narrative (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Mar. 31, 2023 | Mar. 31, 2022 | Mar. 31, 2023 | Mar. 31, 2022 | |
Income Tax Disclosure [Abstract] | ||||
Income tax expense | $ 2,517 | $ 2,902 | $ 5,550 | $ 38,318 |
Discrete income tax expense | 30 | 700 | 100 | 33,500 |
Realized gain on disposal of equity method investments, net | 4,500 | 396,000 | ||
Income tax expense net of discrete tax expense | $ 2,500 | $ 2,200 | $ 5,400 | $ 4,700 |
Estimated effective income tax rate excluding discrete income tax expense | (15.20%) | 7.40% | 28.40% | 6% |
Pre-tax book income | $ 16,400 | $ 30,000 | $ 19,000 | $ 80,400 |
Other discrete income tax items | 100 | |||
Unrecognized tax benefits | 8,700 | 8,700 | ||
Unrecognized tax benefit that would impact effective tax rate | $ 5,700 | $ 5,700 |
Segment and Geographic Inform_3
Segment and Geographic Information - Narratives (Details) $ in Thousands | 1 Months Ended | 3 Months Ended | 9 Months Ended | ||
Feb. 28, 2023 USD ($) | Mar. 31, 2023 USD ($) | Mar. 31, 2022 USD ($) | Mar. 31, 2023 USD ($) Segment | Mar. 31, 2022 USD ($) | |
Segment Reporting [Abstract] | |||||
Number of operating segments | Segment | 1 | ||||
Number of reportable segments | Segment | 1 | ||||
Revenues from External Customers and Long-Lived Assets | |||||
Revenue | $ | $ 132,560 | $ 203,239 | $ 529,796 | $ 583,593 | |
Service | |||||
Revenues from External Customers and Long-Lived Assets | |||||
Revenue | $ | $ 45,000 |
Segment and Geographic Inform_4
Segment and Geographic Information - Revenue by Location and Product Type (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Mar. 31, 2023 | Mar. 31, 2022 | Mar. 31, 2023 | Mar. 31, 2022 | |
Revenues from External Customers and Long-Lived Assets | ||||
Revenue | $ 132,560 | $ 203,239 | $ 529,796 | $ 583,593 |
Power discrete | ||||
Revenues from External Customers and Long-Lived Assets | ||||
Revenue | 80,962 | 140,027 | 363,117 | 404,902 |
Power IC | ||||
Revenues from External Customers and Long-Lived Assets | ||||
Revenue | 47,416 | 60,904 | 159,708 | 169,115 |
Packaging and testing services | ||||
Revenues from External Customers and Long-Lived Assets | ||||
Revenue | 552 | 2,308 | 3,341 | 9,576 |
License and development services | ||||
Revenues from External Customers and Long-Lived Assets | ||||
Revenue | 3,630 | 0 | 3,630 | 0 |
Hong Kong | ||||
Revenues from External Customers and Long-Lived Assets | ||||
Revenue | 106,940 | 164,555 | 438,537 | 472,399 |
China | ||||
Revenues from External Customers and Long-Lived Assets | ||||
Revenue | 14,360 | 31,883 | 58,104 | 91,958 |
South Korea | ||||
Revenues from External Customers and Long-Lived Assets | ||||
Revenue | 1,083 | 2,745 | 7,622 | 8,862 |
United States | ||||
Revenues from External Customers and Long-Lived Assets | ||||
Revenue | 4,245 | 3,534 | 16,701 | 9,004 |
Other countries | ||||
Revenues from External Customers and Long-Lived Assets | ||||
Revenue | $ 5,932 | $ 522 | $ 8,832 | $ 1,370 |
Segment and Geographic Inform_5
Segment and Geographic Information - Long-lived Assets (Details) - USD ($) $ in Thousands | Mar. 31, 2023 | Jun. 30, 2022 |
Revenues from External Customers and Long-Lived Assets | ||
Property, plant and equipment, net and land use rights, net | $ 381,119 | $ 342,340 |
China | ||
Revenues from External Customers and Long-Lived Assets | ||
Property, plant and equipment, net and land use rights, net | 115,944 | 105,326 |
United States | ||
Revenues from External Customers and Long-Lived Assets | ||
Property, plant and equipment, net and land use rights, net | 261,142 | 232,731 |
Other countries | ||
Revenues from External Customers and Long-Lived Assets | ||
Property, plant and equipment, net and land use rights, net | $ 4,033 | $ 4,283 |
Commitments and Contingencies -
Commitments and Contingencies - Purchase Commitments (Details) - USD ($) $ in Millions | Mar. 31, 2023 | Jun. 30, 2022 |
Raw materials, wafers, and packaging and testing services puchase commitments | ||
Purchase Commitment, Excluding Long-term Committment [Line Items] | ||
Purchase commitment, amount | $ 120.6 | $ 89.9 |
Property and equipment purchase commitments | ||
Purchase Commitment, Excluding Long-term Committment [Line Items] | ||
Purchase commitment, amount | $ 11.9 | $ 63.4 |
Commitments and Contingencies_2
Commitments and Contingencies - Contingencies and Indemnities (Details) - USD ($) | Mar. 31, 2023 | Jun. 30, 2022 |
Indemnification Agreement | ||
Loss Contingencies [Line Items] | ||
Indemnifications accrual | $ 0 | $ 0 |